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ABSTRACT
This descriptive study was done 1) to explore and describe the
proportional distribution of breast, cervical and colorectal cancers by stage (a
proxy measure of availability, access, and utilization of secondary prevention
strategies) in northern Saskatchewan First Nations and non-First Nations in
comparison to southern Saskatchewan First Nations and non-First Nations; 2)
to assess the impact of stage and age on the survival patterns for these
cancers in northerners and First Nations whose survival patterns have been
shown by previous research to be equal or poorer in comparison to
southerners. Univariate and multivariate survival analyses were carried out to
ascertain the impact of the different proportions of stage for each study
group on survival. Stage at time of diagnosis is a proxy assessment of
secondary prevention services, which include formal screening programs.
Data for this study was obtained from the Saskatchewan Cancer
Registry, which has been maintaining cancer data since 1932. Cancer stage at
time of diagnosis information is complete in the registry for different years
for each cancer site. Hence data for breast cancer was for the years 1970 to
1995; cervical cancer data for the years 1980 to 1995; colorectal cancer data
for the years 1990 to 1995.
The proportion of cancer cases for each site by TNM stage and age
were compared among the four study groups. First Nation and northern
populations were found to have a larger proportion of diagnoses at a later
stage in comparison to the southern non-First Nation group.
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Using Cox's proportional hazards model, both stage and age at time of
diagnosis were found to be significant predictors of survival for all study
groups. Age and stage adjusted relative risks were calculated and found to be
significant in comparison to the southern non-First Nation group for cancer of
the breast (RR =1.81 P =0.013). For cervical cancer the relative risk of dying
of cervical cancer for southern First Nations in comparison to southern non-
First Nations was found to be 1.38 but this was not statistically significant (p =
0.097). For colorectal cancer, the relative risk of dying of colorectal cancer
was found to be better for northern First Nations in comparison to southern
non-First Nations (RR = 0.59), however this was not statistically significant (p
= 0.45).
This study showed that despite adjusting for stage and age at time of
diagnosis, there were still some unexplained differences in the survival
pattern of northern First Nations, northern non-First Nations and southern
First Nations in comparison to southern non-First Nations. Hypotheses as to
what these unexplained differences are have been offered. These include
differences in socio-economic status as well as availability, accessibility,
attitudes towards and knowledge of secondary prevention strategies. Further
study into these unexplained differences should be carried out.
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1. Introduction
Prevention and early detection strategies for breast, cervical and
colorectal cancers are available yet mortality rates are high or rising among
First Nation groups in North America. Examining survival patterns and factors
that influence these patterns can perhaps give insight as to why this is
happening.
1.1 Nomenclature
Most Indian bands in Saskatchewan refer to themselves and are
referred to by others as "First Nations". For the purpose of this study the term
"First Nations" will be used to refer to people who had identified themselves
to Saskatchewan Health as being registered members of an Indian band, under
provisions of the federal Indian Act. Saskatchewan Health's registry of
persons eligible for health services benefits distinguishes between First
Nations and other Saskatchewan residents. Non-treaty Aboriginal people and
Metis are not uniquely identified in Saskatchewan Health's registry of persons
and therefore can not be identified for separate comparison analyses. All
Saskatchewan people who are not identified as a First Nation in the Cancer
registry data, including those people without treaty status, Metis, and people
of other races, will be referred to as "Non-First Nations" in this study. (1 ) For
American studies referred to, the American term for First Nations will be
used, this being "American Indian".
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1.2 The Problem
North American First Nations have experience well documented health
inequalities compared to non-First Nations. Studies of mortality, using vital
statistics information, morbidity, using hospitalization information and
disease specific studies such as cancer, using cancer registry as well as the
afore mentioned sources of data, have all given evidence to this.(2-4) Within
Saskatchewan, while there is some information on cancer incidence and
survival, little of this information pertains to the First Nation population of
the province as a whole and even less is known about the northern population
(First Nation and non-First Nation). Looking at cancer in northern
Saskatchewan, Gillis et al's study entitled "Cancer Incidence and Survival of
Saskatchewan Northerners and Registered Indians, 1967-1986" was one of the
first cancer studies conducted on the population of Northern Saskatchewan.
In their analysis, an increasing age-adjusted incidence rate of lung, breast and
cervical cancer over time was demonstrated in the northern population of
Saskatchewan, as compared to the rest of the province.(5) In a subsequent
study on lung, breast, and cervical cancer incidence and survival in northern
Saskatchewan, Irvine et al. found lung, breast, and cervical cancer survival to
be equal or less for the northern and First Nations groups.(6) For both of
these studies the possible explanations for the differing survival rates were
outlined. Cancer survival is influenced by such factors as age, extent or stage
of disease, cancer histology, response to treatment, access to and utilization
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of medical care, compliance with therapy, general state of health, and
socioeconomic circumstances.(6) Irvine et al went on to suggest that
Northerners and Registered First Nations poorer survival for cancer may be
attributable to differences in stage of cancer at diagnosis and medical care
access, utilization, and compliance with therapy. (6) In addition to this,
survival analysis is prone to lead-time bias. Lead-time bias can be defined
using the following example. When survival curves of two groups are to be
compared, it is important that both have the same starting point. Consider a
study to evaluate the efficacy of a new procedure for the early diagnosis of a
disease. Even if detecting the disease early does not prolong life, it might
appear to do so if survival is measured from the date of early diagnosis
instead of from the usual diagnosis date resulting from traditional methods.
(7) Survival without stage assessment is prone to lead-time bias. For this
study lead-time bias may be present when comparing survival between
northern First Nations, northern non-First Nations, southern First Nations, and
southern non-First Nations. Although survival is calculated from time of
diagnosis for all groups, the stage of disease for each study group may be
different at time of diagnosis. By controlling for this and thus in essence
making it so that all study groups are at effectively the same stage of disease
at time of diagnosis, the stage adjusted survival time for the cancer of
interest may be less biased. This thesis sets out to look at the role of
differing stage at diagnosis and medical care access with respect to differing
survival rates between the northern population of Saskatchewan and the
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south. This is keeping in mind the issue of lead-time bias and its impact on
mortality.
In the most recent study of cancer done in Saskatchewan (1999), it has
been found that incidence rates among First Nations and northerners for
cervical cancer are higher and more recently for colorectal cancer, are rising
more quickly in comparison to the province as a whole. While breast cancer
incidence has been found to be lower than the rate for the whole province, it
has been increasing over the last twenty-five years. (8) Cancer survival was
not studied in the most recent study.
In 1998 for aU of Canada, breast and colorectal cancers were second
and third respectively in number of estimated new cancer cases, number one
being lung cancer.(9) Cervical cancer was much lower on the list but this
information was for aU ethnic groups combined (First Nations and non-First
Nations together). Incidence rates for aU of Canada show a similar pattern,
for males the top three are; cancer of the prostate, lung cancer and
colorectal cancer. For females the top three are; breast cancer, lung cancer
and colorectal cancer. (9)
The burden of cancer among cancer patients can be described in many
ways (mortality, incidence), but the most direct representation of the
severity of disease is provided by survival rates. This is in contrast to
incidence rates, which indicate how frequently cancer occurs, and mortality
rates, which indicate how frequentLy deaths due to cancer occur.(10) Having
observed through other studies in Saskatchewan that Northerners and First
4
Nations experience incidence rates for cervical, breast, and colorectal
cancers that are interestingly different in comparison to the non-First Nation
population of Saskatchewan, it is of some interest to gain knowledge of the
severity of these cancers. This can be measured by comparing survival
between these population groups. Factors that influence survival such as
stage of disease at time of diagnosis can also be examined, and this may help
offset the effects of lead-time bias that occur when looking at survival alone.
It is important to study cervical, breast and colorectal cancers in that
they are:
1. Two of the top three cancer diagnoses in Canada and Saskatchewan, with
lung cancer being number one.
2. There are clear secondary prevention strategies for cervical, colorectal,
and breast cancers. i.e.) PAP smear, fecal occult blood, digital examination
and sigmoidoscopy/ colonoscopy-screening, and mammography, clinical breast
examination, and breast self-examination respectively
3. The staging information in the Saskatchewan Cancer Registry database is
quite good for these three sites.
Both lung and prostatic cancers are not being studied, as the staging
information in the Saskatchewan Cancer Registry database is quite poor for
these sites. As well, prostatic cancer has a low proportion of cases among
First Nation populations and as this is one of the groups of interest in this
study, it will not be studied.
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By examining survival among the northern population and First Nations
in more detail an assessment of their access to secondary prevention can be
ascertained.
1.3 Purpose of the Study
The aim of this study is to explore and describe cancer survival
patterns in Northern Saskatchewan First Nations and non-First Nations in
comparison to southern Saskatchewan First Nations and non-First Nations.
This study also serves the purpose to explore factors, such as staging at time
of diagnosis, that could explain the disparity in survival rates for cervical,
colorectal, and breast cancer experienced by northerners (First Nations and
Non-First Nation) in comparison to southerners (First Nation and Non-First
Nation). Staging can be used as a proxy for access and utilization of
secondary prevention strategies. The study was stimulated by inquiries from
northern community leaders and health workers regarding cancer trends in
northern Saskatchewan.
1.4 Relevance 8: Significance
Population-based survival rates and survival rates adjusted for factors
such as stage at diagnosis, treatment, age, etc. can be used to monitor
cancer patient care, and can serve as a basis for evaluating the impact of
treatment and other cancer control activities such as early detection
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programs. By comparing survival rates between different population groups in
the province, focusing on First Nations, the cancer burden and the effect of
the provinces cancer control program as it pertains to northerners and First
Nations can be better understood. This can then help guide health care
planners and policy makers as they develop strategies for cancer control. For
researchers, survival information, along with factors that influence survival,
can be used to identify areas where new research is needed into the
determinants of survival among cancer patients and where further advances
are needed to control the suffering caused by cancer. (10) Survival by stage
at time of diagnosis of disease can be assessed in comparison to unadjusted
survival.
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2. Review of the Literature:
2.1 Cancer of the Female Breast
Breast cancer is the most common malignancy among women in
Western society. Over the past decade it has become apparent that breast
cancer inddence rates are increasing steadily, whereas mortality rates have
remained relatively constant. This increase in incidence rates may be due to
increased use of breast cancer screening. At the current time it is difficult to
identify risk factors that can explain a major part of the incidence. Thus,
with the current knowledge, the most important strategy to reduce breast
cancer mortality is early detection through secondary prevention strategies
such as breast cancer screening programs.(11) Beyond formal screening
programs, secondary prevention strategies also include knowledge of breast
self-examination and annual examination of the breasts by a physician or
health care professional.
2.1.1 Breast Cancer Incidence
Breast cancer is the leading type of cancer in Canadian women
(excluding skin cancer), with 19,300 new cases expected to be diagnosed in
1998. It is the second leading cause of cancer death among women at 5,300
deaths, it is behind lung cancer with 6,500 expected deaths.(9) Breast cancer
is thus a very important health problem for women in Canada. It is a disease
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that often strikes women in the prime of their life, at the peak of their work
and family responsibilities. From 1990-95 in Saskatchewan, cancer of the
breast follows the same incidence trend as the rest of the country. This site
has the highest incidence of any cancer for females. Among northern
Saskatchewan residents (First Nation and non-First Nations), northern First
Nations on reserve, and First Nations for the entire province, cancer of the
breast has the highest incidence.(8) Studies across North America comparing
First Nation populations with non-First Nations in northern and southern
locations, have shown that the First Nation population experience lower rates
of breast cancer when compared to non-First Nations.(12-15) In a study done
in Saskatchewan from 1967-86 breast cancer incidence rates for First Nations
and northerners revealed a dramatic increase over the 20 year study period,
while the rate remained relatively stable for the province as a whole.(6) In a
more recent study of Saskatchewan cancer incidence trends from 1970 to
1995 (8) similar results were revealed. In the early 1970's the incidence of
female breast cancer among First Nations was low compared to that of the
whole province. During 1970-74, First Nations incidence rate was less than
one fourth of that of the whole province. In the subsequent 25 years, First
Nation breast cancer incidence rose steadily so that by 1990-95 their
incidence has increased nearly four times that of the rate in 1970-74. In
1990-95 the incidence rate for First Nations was still lower than that of the
whole province.
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2.1.2 Breast Cancer Survival
Survival rates for breast cancer are higher than those for most other
cancers. Canada wide, the relative five-year survival rate for breast cancer is
74% based on cases diagnosed between 1980-84.(16) In addition, survival rates
are better for younger women and for women whose cancer was detected at
an early stage. (17) In Saskatchewan, breast cancer survival was studied for
the entire population by Yang et al. and in a separate study by Tan and
Robson. Both of these studies examined cancer for the years 1967-86. (18,
19)1n both of these studies the five-year breast cancer survival rate was found
to be similar to that of the Canadian rate, approximately 74%. Among First
Nations populations, breast cancer survival has been found to be poorer in
comparison to non-First Nations. (6, 12, 20-22) Giuliano et al write that late
stage of breast cancer diagnosis is one of the major factors contributing to
the poorer rate of survival among American Indian women.(12) In Irvine et
al. study from 1967-86, First Nations and northerners in Saskatchewan five-
year breast cancer survival rates were 74%, 70% and n% for the First Nations,
northerners and the province as a whole.(6) Here to the authors suggest
further investigation into the influence of age and cancer stage at diagnosis
on survivaL Mclaughlin et al also suggest that stage at diagnosis is linked to
survival. In their Ontario study of cancer survival for the entire population
(First Nation and non-First Nation) breast cancer survival showed some
improvement over time. They hypothesized that along with other factors this
may be due to enhanced case detection by screening in recent years, which
10
would lead to the identification of more women with disease at an earlier
stage. (1 0)
2.1.3 Breast Cancer Screening
Of the three strategies for cancer control, [prevention(primary),
screening(secondary), and treatment(tertiary)], early detection through
screening currently offers the best chance of reducing overall mortality from
breast cancer.(16, 23, 24) By detecting cancers at an earlier stage, screening
mammography can reduce breast cancer mortality by 30% among women ages
50-69 years, thus survival can be improved. Since the late 1980's, Health and
Welfare Canada has sponsored regular meetings with provincial and territorial
representatives to facilitate development of breast screening programs.(16) In
Saskatchewan a breast screening program was initiated in 1990, targeting
women aged 50 to 69.(16) For northern Saskatchewan, a screening program
was established in 1992 and expanded since that time. (25) Some work has
been done indicating that the number of First Nations participating in
screening programs in other parts of North America is low in comparison to
non-First Nations populations.(12, 23, 26)
2.1.4 Summary
First Nations and northern populations experience lower incidence
rates of breast cancer but these rates have been shown to be rising over time.
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Within these population groups incidence rates are high on their own.
Survival rates for First Nations and northerners in comparison to non-First
Nations have been shown to be slightly worse. By establishing screening
programs, breast cancer cases can be diagnosed at an earlier stage and this
can perhaps lead to better survival outcome.
2.2 Cancer of the Cervix
Cancer of the cervix is the eleventh most frequently diagnosed cancer
among Canadian women (in contrast it is the second most common form of
cancer in women worldwide) and despite being almost completely
preventable through regular screening, continues to be an important cause of
morbidity and mortality. (27)
2.2.1 Cervical Cancer Incidence
In 1998 in Canada, it was estimated that approximately 1400 women
would develop cervical cancer and 400 would die from this disease.(9)
Incidence trends for cervical cancer in Canada have decreased steadily in the
1970's and early 1980's and showed a more moderate decline since the mid
198O's.(27) This decline in incidence is for aU Canadian women, First Nation
and non-First Nation. The likely explanation for this decline in incidence is a
plateau in screening activity for cervical cancer at the national level. (27)
Among First Nations however the incidence description is quite different. It is
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well documented that First Nations women experience much higher incidence
of cervical cancer in comparison to non-First Nations. (5, 14, 27) (28, 29)
Among northern populations, cancer of the cervix incidence has also been
found to be high. (27, 30-32) In Saskatchewan, from 1967-86 cervical cancer
incidence has decreased for the entire Saskatchewan population, however, for
First Nations the incidence has risen over this 20 year study time frame. (6) In
a separate study of cancer in Saskatchewan from 1970-95 the incidence of
cervical cancer among First Nations has been at least 3 times higher than that
of the whole province over the twenty five year study period. The First
Nations incidence peaked in the early 1980's. In the meanwhile, the
incidence for the whole province has been steady during the twenty five year
period. (8)
2.2.2 Cervical Cancer Survival
Survival rates provide a direct indication of disease severity and the
impact of cancer treatment and secondary prevention. In Canada, for
cervical cancer the 5-year survival rates are generally high, at 74% for all
ages. Survival varies depending on age at diagnosis. Generally those women
diagnosed at an early age and early stage have a better prognosis than those
diagnosed at an older age and later stage. (1 0, 33) Cervical cancer survival for
Saskatchewan is similar to the national rates. The five year relative survival
rate for cervical cancer for the entire population of Saskatchewan for the
years 1967-86 was found to be 67.3% for aU ages.(18) A study by Tan et al.
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found that on average the 5-year relative survival rate for all ages was
68%. (19) For First Nations populations survival for cervical cancer has been
shown to be poorer in comparison to non-First Nations populations. (21 ) Irvine
et al. study of northerners and First Nations in Saskatchewan found five-year
cervical cancer survival rates to be 75%, 66% and 76% for First Nations,
northerners and the province as a whole respectively.(6) As with breast
cancer, the authors suggest further investigation into the influence of age and
cancer stage at diagnosis on survival.
2.2.3 Cervical Cancer Screening
Regular screening and early detection can prevent significant morbidity
and mortality due to cervical cancer.(23, 31) The Canadian Task Force on the
Periodic Health Examination recommends annual screening with the Pap
smear after initiation of sexual activity or at age 18. If an organized
screening program is in place with appropriate quality control measures and
information systems, the screening frequency may be reduced (for women
with 2 previous normal smears) to every 3 years until age 69. (27) A series of
national workshops on cervical cancer screening have urged the establishment
of organized, provincial screening programs with centralized laboratory and
information systems. As of April 1998, 3 provinces (B.C., Nova Scotia, and
P.E.I.) have adopted these recommendations in whole or part.(27) In
Saskatchewan in 1997, a Cervical Screening Program was approved and was
said that it will ""become operational in the coming months".(34) Studies in
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Canada and the United States have shown that First Nations women have
lower participation in cervical cancer screening in comparison to non-First
Nations.(23, 29, 31) (35) There have been suggestions that this may be due to
less access to screening programs(26) or other factors such as lack of
knowledge of Pap smear, feelings of embarrassment, lack of community care
or lack of culturally suitable health care services. (29, 36)
2.2.4 Summary
It has been well documented that cervical cancer can be prevented
through thorough screening programs. Diagnosing cervical cancer at an early
stage or even a pre-cancerous stage is possible through diligent screening
programs. Incidence rates for First Nations women and northerners are higher
than non-First Nations. Survival rates for First Nations and northerners have
been shown to be equal or poorer than non-First Nations. Poorer survival may
be attributable to less access to screening programs or other factors.
2.3 Colorectal Cancer
Cancer of the colon and rectum together constitute the third most
important cancer in each sex in most Western countries. When both sexes are
considered together colorectal cancer becomes the second most frequently
diagnosed cancer behind lung cancer.
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2.3.1 Colorectal Cancer Incidence
Colorectal cancer is the third most common site in terms of cancer
incidence, and the second-ranked cause of cancer death among Canadians. In
1998, 16,500 new cases of colorectal cancer are expected to be diagnosed in
Canadian men and women, this is compared to 20,400 new cases of lung
cancer, 19,300 female breast cancers, and 16,100 prostate cancers. (9) The
estimated 7,300 deaths from colorectal cancer place it ahead of the 5,300
expected deaths due to breast cancer and 4,300 prostate cancer deaths.(9)
Canada wide, incidence and mortality rates for colorectal cancer continue to
decrease, particularly among women, although the reasons are not
completely understood. Research conducted in the
United States suggests that more widespread use of methods for early
detection may allow for more effective treatment for earlier staged disease,
particularly among the elderly. Also, some evidence suggests that lifestyle
changes such as diet may have contributed to the declines.(9) Although there
has been a decline, cancers of the colon and rectum still represent an
important health problem for Canadians.
Within Saskatchewan approximately 580 new cases of colorectal cancer
have been estimated for 1998.(9) In a study for the years 1970-95 incidence
rates for the entire provincial population, northerners, and First Nations, have
risen over this time period(8). In the early 1970's, the incidence for colorectal
cancer among First Nations in Saskatchewan was low compared to that of the
province as a whole. During 1970-74, First Nations colorectal cancer
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incidence rate was less than one half of that of the whole province. In the
subsequent 25 years, First Nations colorectal cancer incidence took a
dramatic increase so that by 1990-95 First Nations incidence was comparable
to that of the whole province. In the meantime, the incidence of colorectal
cancer for the whoLe province has increased onLy sLightly. In the early 1970's
the northern First Nations incidence of colorectal cancer has been lower than
that of the First Nations of the entire province. By 1990-95 however,
northern First Nations incidence are the same as that of aU First Nations
(north and south) of Saskatchewan. Many other studies have shown that
colorectal cancer incidence is increasing among northerners and registered
Fist Nations populations in comparison to non-First Nations populations. (37-
39)
2.3.2 Colorectal Cancer Survival
Colorectal cancer has a fair prognosis with a five-year reLative survival
rate of 54% among femaLes and 52% among males for aLL ages combined based
on recent data from Ontario. (1 0) Within Saskatchewan Tan et al found that on
the average the five-year relative survivaL rate for cancer of the coLon is 54%
for maLes and females combined. This is lower than the 60% five-year survival
rate for aLL cancers combined for the entire Saskatchewan population
calculated by Gillis et aL.(5) Among northern populations and First Nations,
survival for colorectaL cancer has been shown to be poorer than non-First
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Nations. (21 , 40) Among Saskatchewan First Nations and northerners, the
survival rates for colorectal cancer have yet to be published in any detail.
2.3.3 Colorectal Cancer Screening
It has been suggested that recent declines in mortality for colorectal
cancer may be due to more widespread use of methods for early detection
which may allow for more effective treatment for earlier staged disease. (41 )
There is no formal colorectal screening program per se in Canada at the
present time. The Canadian Task Force on the Periodic Health Examination
has concluded that there is insufficient evidence to support the inclusion or
exclusion of fecal occult blood, sigmoidoscopic or colonoscopic screening of
asymptomatic individuals over the age of 40 years as colorectal cancer
screening methods.(42) Some rectal exam screening is also done. There is
some screening in an unorganized way in Canada however.(25) Colorectal
cancer if detected early can be effectively treated.(33) Among northerners
and First Nations populations, high incidence and poorer survival suggest a
need for intensified secondary prevention strategies for colorectal cancer.(43)
2.3.4 Summary
Incidence rates for colorectal cancer among First Nations and non-First
Nations are ranked third highest behind cancer of the lung and breast cancer.
Incidence trends for the entire population (First Nation and non-First Nations)
have declined somewhat over the last decade. For northerners and First
Nations populations incidence rates have increased over the last 25 years and
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now are comparable to those of non-First Nations. In studies conducted
outside of Saskatchewan, survival for this cancer site has been found to be
poorer for First Nations and northerners in comparison to non-First Nations.
Early detection can lead to better survival. It can be said therefore that
colorectal cancer is a significant problem for First Nations and northerners
and with early detection strategies its survival could be improved.
2.4 Cancer Stage at Diagnosis and Survival
By controlling for cancer stage at diagnosis when examining cancer
survival one can asses such factors as access to and utilization of secondary
prevention strategies. By diagnosing some cancers, including breast, cervical
and colorectal cancers, at an early stage, there is a better chance that the
cancer can be treated with better success and thus possibly improve survival.
Cancer survival for aU causes comparing northerners, First Nations and
the population as a whole in Saskatchewan has been shown to be different.
Northerners and First Nations experience poorer survival than the
Saskatchewan population as a whole (First Nation and non-First Nation).
Particularly interesting is the finding that, even though the average age of
diagnosis of cancer is 10 and 6 years younger in First Nations and northerners
respectively their survival is poorer even when the survival analysis has not
adjusted for this age difference. Generally one would expect better survival
when cancer is diagnosed at younger ages.(5) Gillis et al go on to point out
that stage of cancer at diagnosis may explain this poorer survival.
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Furthermore they point out that American research has indicated that First
Nation populations tend to have more advanced disease at the time of cancer
diagnosis. Other studies have also shown this(40, 44).
There have been many studies that have explored the relationship
between cancer survival and stage of cancer at time of diagnosis. (20, 21, 40,
45-48) These studies have had mixed conclusions. Sugarman et al conducted
a study in 1994 on First Nations in Washington State concentrating on
prostate, breast, cervical, and colorectal cancers. They found that the
cancer stage at diagnosis distribution for First Nations was not significantly
different from Whites. Their survival analysis showed that after adjustment
for such factors as age, stage at diagnosis, lack of cancer treatment, and
residence in a non-urban county, that First Nations poorer survival persisted
in comparison to Whites. (21 ) Frost et allooked at breast cancer survival
among New Mexico Hispanic, American Indians, and non-Hispanic women
adjusting for first treatment and stage of disease at diagnosis. They used
stage distribution, five-year relative survival curves and Cox proportional
hazards model to assess the influence of stage on survivaL They found that
the stage distribution changed for aU three groups between the time point of
1973-82 to 1983-92. The later time point distribution according to stage of
cancer at diagnosis was mostly local compared to 1973-82. In their 5-year
relative survival analysis the American Indians group and the non-Hispanic
whites experienced statistically significant better survival when the stage at
diagnosis was locaL The Cox model indicated that American Indian women
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experienced poorer survival in comparison to non-Hispanic whites during both
time periods. (20) Gilliland et al examined cancer survival comparing
American Indians, Hispanic and non-Hispanic whites in New Mexico and
Arizona controlling for such factors as age, gender, stage at diagnosis,
histologic grade, and treatment. They found that over time survival had
improved for each ethnic group however this improvement was seen more in
the non-Hispanic whites than the American Indians and Hispanics also,
disparities in survival for the different ethnic groups widened over the study
time period (1969-1994). They went on to remark that controlling for the
distribution of age, gender, stage at diagnosis, histologic grade, and
treatment did not completely explain the improved survival or ethnic
disparities regarding survival. They did mention factors such as lower
socioeconomic status, poverty and lower educational attainment as possible
contributors to advanced stage at diagnosis and poorer survival. Zhang et al
recently examined the impact of stage and treatment on short-term survival
of lung, colorectal, and breast cancers. They calculated relative survival
rates according to age, sex, stage, and treatment. They also calculated
multivariate relative survival to examine the relative risk of dying from cancer
and 95% confidence intervals. They found that those individuals diagnosed
with advanced (TNM stage III or IV) stages of cancer had significantly lower
relative survival rates than those diagnosed at early stages (TNM stage I or II).
For colorectal cancer, their results suggest that age and sex have little impact
on cancer survival but TNM stage and initial treatment strongly influence 2-
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year relative survival rates. For breast cancer, their study demonstrated that
TNM stage as well as age at diagnosis play an important role in breast cancer
survival. They go on to conclude that TNM stage is the strongest prognostic
factor for the survival of lung, colorectal and breast cancer patients. Initial
treatment and age also play important roles. Certain effect modifications
between age and stage need to be investigated in further studies.
Cancer stage at diagnosis may be used as a proxy measure for access to
diagnostic and or preventive services especially in the context of the north of
Saskatchewan. As Gillis et al point out, First Nations and northerners on
social assistance experience few financial problems in accessing hospital and
physician services when they are required. As with the all other residents of
Saskatchewan, there are free physician and hospitalization services through
the universal health plan. First Nations people and northerners on social
assistance benefit from health travel coverage; however, even with this
assistance, access is not always easy. Individuals living in the north must
travel between 200 and 800 miles to a secondary or tertiary hospital. Thus
diagnosis may be delayed and follow-up treatment is made difficult.(5) One
can deduce that a diagnosis at early stage is perhaps related to readily
accessible diagnostic and treatment services.
Factors such as cancer stage at time of diagnosis, age and treatment
are important variables to examine when describing and comparing the
survival patterns of different populations. By controlling for these factors one
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can better understand the severity of cancer in a population and hence try to
impact prevention and treatment strategies.
2.5 Summary
Breast, colorectal and cervical cancer incidence is high or increasing or
relatively high among northerners and First Nations as compared to non-First
Nations. Survival for these three sites is poorer or equal for northerners and
First Nations in comparison to non-First Nations populations. Colorectal,
breast and cervical cancers have secondary prevention strategies attached to
them, they all have improved survival with early detection. It is useful to
examine stage specific distribution and survival for these sites to see what
influence stage has on survival. Stage can be used as a proxy measure for
access to secondary prevention and treatment services, especially in the
context of the north.
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3. Objectives:
This study serves to:
1. Explore and describe the Breast, Cervical, and Colorectal cancer
distribution by stage at the time of diagnosis of the northern First Nation,
northern non-First Nation, southern First Nation, and southern non-First
Nation population groups in Saskatchewan.
2. Explore and describe the unadjusted Breast, Cervical, and Colorectal
cancer survival pattern among the northern First Nation, northern non-First
Nation, southern First Nation, and southern non-First Nation population groups
in Saskatchewan.
3. Ascertain what role if any, severity of cancer at time of diagnosis,
measured by stage of cancer at time of diagnosis, has in survival of breast,
cervical, and colorectal cancers among northern First Nation, northern non-
First Nation, and southern First Nation populations in comparison to southern
non-First Nations.
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4. Methods:
4.1 Design
This is a descriptive epidemiological study of cancer incidence and
survival for the period of 1970 to 1995 for cancer of the female breast, cancer
of the cervix, and colorectal cancer. The setting for the study is
Saskatchewan, with the four study groups being, northern First Nations,
northern non-First Nations, southern First Nations, and southern non-First
Nations. Comparisons will be made between these groups. Data from the
Saskatchewan Cancer Registry will be analyzed.
4.2 Setting and Population
4.2.1 Setting
Northern Saskatchewan can be considered a unique population given its
geographic and ethnic make-up. It is defined geographically by Saskatchewan
Health as roughly the northern half of Saskatchewan and historically has been
the Northern Administrative District and Northern Health Services Branch area.
It coincides with the boundaries of Census Division #18, and now approximates
the health service areas of the Mamawetan/Churchill River Health District,
Keewatin Yathe' Health District, and the Athabasca Health Authority area. (see
Appendix A) Health care services are provided in a somewhat different manner
in the north as compared to the south. Physicians from larger centres in the
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north travel regularly to smaller communities in the north to provide routine
medical care. In most of the communities that do not have resident physicians,
primary care nurses that live in the community, along with community health
workers and other allied health workers, provide both clinical diagnostic and
treatment services as well as public health services. (1 ) The ethnic makeup of
the north compared to the south is quite different. First Nations comprise just
over half of the population of Northern Saskatchewan, however just over 7% of
the provindal population is First Nation in 1993/94. The northern population of
Saskatchewan in 1993-94 is spread over more than 40 communities, a few of
which have no road access.
4.2.2 Population
For the purpose of this study, the Saskatchewan population will be
divided into four mutually exclusive groups. This is outlined in the following
table and described in more detail following:
Table 4.2.2.1 - Study Groups used for this study
Location Population Group
North
South
First Nation
First Nation
Non-First Nation
Non-First Nation
Residents of northern and southern Saskatchewan were grouped as First
Nations and Non-First Nations
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As in the Irvine et al study on hospitalization for northern Saskatchewan
residents and Saskatchewan First Nations, the definition of the northern
residents is persons with residence codes in the area covered by the previous
Northern Health Services Branch. This now approximates the new service
areas of Mamawetan/ChurchiU River Health District, Keewatin Yathe' Health
District, and the Athabasca Health Authority area. Those in the south are
those persons not in the area.(2). For more detail of what communities were
used to define the north see Appendix B.
4.3 Data
The data used in the study is derived from the Saskatchewan Cancer
Registry, which has been maintaining cancer data since 1932.
4.3.1 The Saskatchewan Cancer Registry
The Saskatchewan Cancer Foundation is an autonomous body
responsible for the provincial Cancer Control Program. It is incorporated
under the Saskatchewan Cancer Foundation Act; its board of governors is
appointed by lieutenant Governor-in-Council. The Saskatchewan Cancer
Program encompasses prevention, detection, diagnosis, treatment, and
follow-up of patients with malignant or premalignant disease.(49) Cancer
services data are maintained in the population-based registry which has a
record of aU people in Saskatchewan who have been diagnosed as having
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cancer. The registry was established in 1932, but complete computerized
data (all cancer sites) are available since 1967; pre- 1967 data are being
computerized retroactively. There have been no major changes in data
collection since 1985. The registry increases by about 6,000 cases per year
(including non-melanoma skin cancer and in-situ cancers); the database
includes approximately 137,000 individual patients and over 170,700 case
records (the difference indicates the number of patients with cancer of two
or more primary sites). Within Canada, patients who move out of province
receive continued surveillance through the appropriate provincial cancer
clinic. All cases of invasive cancer are maintained on a follow-up program for
a minimum of 20 years. The rate of loss-to-follow-up is approximately 3%.
The Saskatchewan Cancer Foundation Act dictates that information from
medical professionals and hospital records required to complete the cancer
registration must be provided upon request. All pathology reports indicating a
cancer diagnosis are forwarded to the Cancer Clinics, as are death certificates
with a cancer diagnosis.(49)
The cancer registry contains patient identification, case, death, and
review information. Cancer site data are coded using International
Classification of Diseases for Oncology (ICDO) Version 2; death information is
coded using International Classification of Diseases version 9 (ICD-9).
The basic information include:
1. Patient Identification:
- health services number (encrypted for the analysis for confidentiality)
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2. Case Information:
- incLuding information on registration, finaL diagnostic information
(e.g. ICDO-T, ICDO-M, grade, Laterality, dates of diagnosis, method of
diagnosis, TNM Stage, metastases at diagnosis).
- residence, age and gender information
3. Death Information:
- primary and secondary cause;
- disease status at death.
4. Review Information:
- including review date, recurrence, metastases, treatment,
performance. (48)
4.3.2 Data for this study
The data for this study has been obtained from the Saskatchewan
Cancer Registry. As this study is examining stage information for breast,
coLorectaL and cervicaL cancer sites, three data files have been obtained.
Each file covers different time points. This can be expLained as foLLows. The
data quality for the stage variable is different for different cancer sites. As
there are data quality issues with the stage variable, different time points for
stage will be used. For breast cancer the stage variable is complete from
1970-95 and therefore diagnoses occurring from the years 1970 to 1995 will be
used. For colorectaL cancer the stage variable is complete from 1990-95 and
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therefore diagnoses occurring from the years 1990 to 1995 will be used. For
cervical cancer the staging variable is complete from 1980-95 and therefore
diagnoses occurring from the years 1980 to 1995 will be used. Hence, the
three data files are as follows:
1. Breast cancer data for the years 1970 to 1995
2. Cervical cancer data for the years 1980 to 1995
3. Colorectal cancer data for the years 1990 to 1995
4.3.3 Data limitations
Given the high quality of medical care and universal coverage in
Saskatchewan, missed diagnoses should be uncommon and therefore data
quality is quite good. This is with the exception of the staging variable
mentioned above.
4.4 Method of Analysis
This section describes the general methodology used in this study.
4.4.1 Stage
Cancer staging systems describe how far cancer has spread
anatomically. The stage is one of the most important factors in determining
both the treatment and prognosis. The concept of stage is applicable to
almost all cancers except for most forms of leukemia. The cancer staging
system used in this study is the "TNM" system where TNM stands for Tumor,
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Nodes and Metastases. Each of these is classified with a number to give the
total stage. Thus a T1 N1 MO cancer is defined as having a T1 tumor, N1 lymph
node involvement, and no metastases.
T - T Classifies the extent of the primary tumor, and is normally given as TO
through T4. TO represents a tumor that has not even started to invade the
local tissues. This is called "In Situ". T4 on the other hand represents a large
primary tumor that has probably invaded other organs by direct extension and
is usually inoperable.
N - N classifies the amount of regional lymph node involvement. It is
important to understand that only the lymph nodes draining the area of the
primary tumor are considered in this classification. Involvement of distant
lymph nodes is considered to be metastatic disease. The definition of just
which lymph nodes are regional depends on the type of cancer. NO means no
lymph node involvement while N4 means extensive involvement. In general
more extensive involvement means some combination of more nodes involved,
greater enlargement of the involved nodes, and more distant (but still
regional) node involvement.
M - M is either MO if there are no metastases or M1 if there are metastases.
The exact definitions for T and N are different for each different kind of
cancer. The various combinations of T, N, and M are grouped to describe the
stage of the cancer numerically into four stages(50). These are: for breast
cancer and cervical cancer TNM stages I, II, II, and IV. Colorectal cancer will
be divided into four comparable stages using the Dukes system of staging
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classification, Dukes stage A, B, C, and D. Cancer staging is done at the time
of diagnosis. For the descriptive and survival analyses stage will be used as a
categorical variable.
4.4.2 Age-groups
Within the cancer registry data, age at time of diagnosis is recorded.
For the purpose of the descriptive analysis of the data for each cancer site,
age-groupings will be constructed. For cancer of the breast the age-groups
will be as follows: 14 to 39, 40 to 49, 50 to 64, and 65 &above. The
youngest case in the breast data is 14 years old and therefore the age-groups
start at 14 to 39. The 40 to 49 age-group is a pre-screening age-group. The
50 to 64 age-group contains the age at which breast cancer screening is
targeted (50 and above). For cervical cancer the age-groups are as follows:
18 to 34, 35 to 49 , 50 to 69, 70 and above. Screening for cervical cancer
starts at age 18 or after initiation of sexual activity. For colorectal cancer
the age-groups are as follows: 20 to 49, 50 to 64, 65 and above. For the
survival analysis age will be used as a continuous variable.
4.4.3 Survival
Cancer survival is an indicator which quantifies the effects of cancer
detection and treatment on the natural history of the disease. It can be
simply expressed as the percentage of patients alive at a certain point in time
after the first diagnosis.
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Survival analysis takes the survival times of a group of subjects and
generates a survival curve, which shows how many of the members remain
alive over time. Survival time is usually defined as the length of the interval
between diagnosis and death. The major mathematical complication with
survival analysis is that you usually do not have the luxury of waiting until the
very last subject has died of old age; you normally have to analyze the data
while some subjects are still alive. Also, some subjects may have moved
away, and may be lost to follow-up. In both cases, the subjects were known
to have survived for some amount of time (up until the time you last saw
them), but you don't know how much longer they might ultimately have
survived. In this case these subjects are known as "censored". Several
methods have been developed for using this "at least this long" information for
preparing unbiased survival curve estimates, the most common being the Life
Table method and the method of Kaplan and Meier(51 ).
The Kaplan Meier method will be used to calculate the crude survival
experience for the four study groups. With the Kaplan-Meier method, the
survival rate is recalculated every time a patient dies. To calculate the
fraction of subjects who survived on a particular day, the number alive at the
end of the day is divided by the number alive at the beginning of the day
(excluding any who were censored on that day from both the numerator and
denominator). This is the fraction of subjects who were alive at the beginning
of a particular day who were still alive at the beginning of the next day. To
calculate the fraction of subjects who survive from day 0 until a particular
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day, the fraction of subjects who survive day 1 is multiplied by the fraction of
those subjects who survive day 2, multiplied by the fraction of those subjects
who survive day 3 •.• multipLied by the fraction who survive day k. This
method automatically accounts for censored subjects, as both the numerator
and denominator are reduced on the day a patient is censored. Because the
product of many survivaL fractions is calcuLated, this method is also called the
product-Limit method. Note that day refers to day of the study, not a
particular day on the caLendar. Day I is the first day of the study for each
subject(51 ).
It is sometimes necessary to know whether survival is influenced by one
or more factors, called "predictors" or "covariates", which may be categoricaL
(such as TNM stage at time of diagnosis) or continuous (such as the subjects
age). For these complicated situations we need a speciaL kind of regression
that lets us assess the effect of each predictor on the shape of the survival
curve. This regression is referred to as the Cox proportional hazards model.
To understand the method of proportional hazards, first consider a
"baseline" survival curve.. This can be thought of as the survival curve of a
hypothetical "completely average" subject, someone for whom each predictor
variable is equal to the average value of that variable for the entire set of
subjects in the study. This baseline survival curve doesn't have to have any
particular formula representation; it can have any shape whatever, as long as
it starts at 1.0 at time 0 and descends steadily with increasing survival time.
The baseline survival curve is then systematically "flexed" up or down by each
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of the predictor variables, while still keeping its general shape. The
proportional hazards method computes a coefficient for each predictor
variable that indicates the direction and degree of flexing that the predictor
has on the survival curve. Zero means that a variable has no effect on the
curve, it is not a predictor at aU; a positive variable indicates that larger
values of the variable are associated with greater mortality. Knowing these
coefficients, we could construct a "customized" survival curve for any
particular combination of predictor values. More importantly, the method
provides a measure of the sampling error associated with each predictor's
coefficient. This assess which variables' coeffidents are significantly different
from zero; that is: which variables are significantly related to survival(52).
The Cox proportional hazards model will be used to calculate the
relative risks and adjusted survival curves for each of the study groups in
comparison with the southern non-Fist Nation group. The Cox proportional
hazards model allows for adjustment of covariates when examining survival.
In this case the covariates will be stage of disease at time of diagnosis and
age at time of diagnosis.
Using the Cox proportional hazards model, comparison of the relative
risk of dying from breast cancer, colorectal cancer or cervical cancer between
study groups can be calculated after controlling for the effects of age and
staging. Two analyses have been undertaken here. The first one uses death
from aU causes as the end point. The second one uses death from breast
cancer as the end point. The survival analysis using death from aU causes is
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calculated for two reasons. One can argue that although the official cause of
death on the death certificate may be something other than breast cancer,
breast cancer may have influenced or had an effect on the death of the
person. Second, using death from all causes allows for larger a number of
cases to be used in the analysis thus increasing the precision of the relative
risk estimate. This can be illustrated by noting the smaller confidence
interval about the relative risk estimate. The relative risk of dying of cancer
for each study group is calculated and compared to the southern non-First
Nations group or the reference group.
Length of survival for this study is defined as the interval between date
of diagnosis and either date of death or date of last follow-up. The statistical
program SPSS 9.0 is used for aU analyses including Kaplan-Meier and Cox
proportional hazards model.
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5. Results
. In this section results for breast, cervix, and colorectal cancers will be
presented. A brief discussion of these results will follow each section
presentation. Some more detailed discussion will be presented in Chapter 6,
Summary Discussion.
5.1 Cancer of the Female Breast
The International Classification of Diseases for Oncology (ICDO) codes for
cancer of the female breast used were; C50.0 to C50.9.
5.1 •1 Distribution of Breast Cancer cases
Table 5.1.1.1 - Distribution of Breast Cancer by study group and TNM stage,
1970-1995
Studl Group TNM Stase Total
I II III IV
Northern FN 6 25 4 3 38
(15.8%) (65.8%) (10.5%) (7.9%) (100.0%)
Northern Non-FN 25 42 2 3 72
(34.7%) (58.3%) (2.8%) (4.2%) (100.0%)
Southern FN 19 66 10 7 102
(18.6%) (64.7%) (9.8%) (6.9%) (100.0%)
Southern Non-FN 4300 4880 804 681 10665
(40.3%) (45.8%) (7.5%) (6.4%) (100.0%)
Total 4350 5013 820 694 10877
(40.0%) (46.1%) (7.5%) (6.4%) (100.0%)
FN = First Nation
679 cases with missing stage data
Table 5.1.1.1 examines the proportion of breast cancer cases over the four
TNM stages by study group. The distribution of cases within the two First
37
Nation groups is quite similar. More striking is the differences between TNM
stage I and TNM stage II between the four study groups. For the northern
First Nation and southern First Nation groups approximately 65% of those
women with breast cancer between the years 1970 and 1995 were diagnosed
at TNM stage II where as only 18.6% and 15.8% were diagnosed at stage I for
Southern First Nations and Northern First Nations respectively. This finding is
in contrast to the northern non-First Nation group and more so the Southern
non-First Nation group. For the Southern non-First Nation group 40.3% of
women were diagnosed with breast cancer at TNM stage I and 45.8% were
diagnosed at TNM stage II. The northern First Nation group had a similar
distribution with 34.7% diagnosed at TNM stage I and 58.3% diagnosed at TNM
stage II.
Table 5.1.1.2 - Distribution of Breast Cancer by study group and age, 1970-
1995
Study Group
Northern FN
Northern Non-FN
Southern FN
Southern Non-FN
Total
FN =First Nation
14 to 39
8
(19.5%)
14
(16.7%)
19
(17.9%)
628
~5.5%1
669
(5.8%)
Age Group Jyears~
40 to 49 50 to 64
10 13
(24.4%) (31.7%)
23 19
(27.4%) (22.6%)
24 32
(22.6%) (30.2%)
1561 3803
(13.8%1 (33.6%1
1618 3867
(14.0%) (33.5%)
38
658: above
10
(24.4%)
28
(33.3%)
31
(29.2%)
5333
{47.1%l
5402
(46.7%)
Total
41
(100.0%)
84
(100.0%)
106
(100.0%)
11325
POO.O%l
11556
(100.0%)
Before examining age comparisons between the four study groups it is
important to mention the differing age structures between these population
groups.
Both the northern and southern First Nation groups have higher
proportion of their populations as infants and children than the southern non-
First Nation population and lower proportions of their populations over age 65
years. The First Nation populations have over twice the proportion of persons
under age 5 compared to the southern non-First Nation group. Conversely the
southern non-First Nation group has almost three times the proportion of
persons aged 50 and over compared to the First Nation populations and to a
lesser extent the northern non-First Nation group.(2) It is therefore important
to keep this differing population structure in mind when age is compared
between the different study groups.
In Table 5.1.1.2 the distribution women diagnosed with breast cancer is
displayed by study group. This table includes the distribution between aU the
different age groups as well as the distribution between the age groups 40 to
49 (pre-screening age) and 50 to 64 (targeted screening ages). Looking at aU
the age groups first, the Northern First Nation group had a fairly even
distribution of cases over the four different age groups. The Southern non-
First Nation group had a much larger proportion of cases at ages 50 to 64 and
65 and above.
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Table 5.1.1.3 - Distribution of Breast Cancer by study group, TNM Stage and
age, 1970-1995
Ase GrouL? ~Years l Total
Study Group TNM 14 to 39 40 to 49 50 to 64 65 and
Stase above
Northern FN I 1 2 1 2 6
(16.7%) (22.2%) (7.7%) (20.0%) (15.8%)
II 4 7 10 4 25
(66.7%) (77.8%) (76.9%) (40.0%) (65.8%)
III 1 2 1 4
(16.7%) (15.4%) (10.0%) (10.5%)
IV 3 3
~3o.0%l ~7.9%)
Total 6 9 13 10 38
!100.0%) ~100.0%) !100.0%) (100.0%) ~100.0%)
Northern Non-FN 3 7 4 11 25
(27.3%) (33.3%) (22.2%) (50.0%) (34.7%)
II 8 12 13 9 42
(72.7%) (57.1%) (72.2%) (40.9%) (58.3%)
III 1 1 2
(4.8%) (5.6%) (2.8%)
IV 1 2 3
(4.8%) (9.1%) !4.2%)
Total 11 21 18 22 72
pOO.O%) (100.0%) (100.0%) (100.0%) !100.0%)
Southern FN 3 2 10 4 19
(16.7%) (8.3%) (33.3%) (13.3%) (18.6%)
II 11 19 16 20 66
(61.1%) (79.2%) (53.3%) (66.7%) (64.7%)
III 3 2 1 4 10
(16.7%) (8.3%) (3.3%) (13.3%) (9.8%)
IV 1 1 3 2 7
(5.6%) ~4.2%) (10.0%) (6.7%) (6.9%)
Total 18 24 30 30 102
(100.0%) (100.0%) (100.0%) (100.0%1 (100.0%)
Southern Non-FN 194 571 1480 2055 4300
(33.0%) (38.4%) (40.6%) (41.6%) (40.3%)
II 320 760 1685 2115 4880
(54.4%) (51.1%) (46.2%) (42.8%) (45.8%)
III 50 97 252 405 804
(8.5%) (6.5%) (6.9%) (8.2%) (7.5%)
IV 24 59 230 368 681
(4.1 %) ~4.0%) ~6.3%) (7.4%1 (6.4%)
Total 588 1487 3647 4943 10665
(100.0%1 (100.0%l (100.0%) (100.0%) (100.0%)
FN = First Nation
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Table 5.1.1.3 examines the distribution of breast cancer by study group, TNM
stage and age. For all study groups throughout aU the age groups the large
majority of cases were either TNM stage I or II. It is interesting to note that
in the southern non-First Nations group for ages 40 to 49 (pre-screening),
38.4% of those women diagnosed with breast cancer were diagnosed at TNM
stage I where 51.1% were diagnosed at TNM stage II. In the age group 50 to 64
(targeted screening) the distribution between TNM stage I and II is different,
with 40.6% diagnosed at stage I and 46.2% diagnosed at stage II. In
comparison to this the two First Nation groups in the age group 40 to 49, over
75% of those women diagnosed with breast cancer were diagnosed with TNM
stage II. In the 50 to 64 age-group the northern First Nation group had 76.9%
of the breast cancer diagnoses at TNM stage II with only 7.7% at stage I. In
the southern First Nation group 53.5% were diagnosed at stage II and 33.3% at
stage I. For the northern First Nation group there appears to be less effect of
the screening program catching cases at an earlier stage. The mammography
screening program in the north was started in 1990, therefore, for this study
only diagnoses for the last five years of data (1990 to 1995) are available
since the screening program inception. The larger proportion of TNM stage II
breast cancer diagnoses in the 50 to 64 age-group in comparison to the
proportion of TNM stage I diagnoses for the northern First Nations group, may
be a reflection of a slightly later start for mammography in the north, but also
perhaps a reflection of clinical breast examination and breast self-
examination practices in this population group. It must be kept in mind
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however that the number of cases for the northern First Nation group in these
age groups is small.
Table 5.1.1.4 - Distribution of deaths among breast cancer patients from
breast cancer and aU causes by study irouP, 1970-1995
Study Group Death from Death from aU
Breast Cancer causes
Proportion of Breast
Cancer Deaths
Northern FN
Northern Non-FN
Southern FN
Southern Non-FN
Total
FN = First Nation
19 21
27 47
33 53
3452 6337
3531 6458
90.5%
57.4%
62.3%
54.5%
54.7%
Comparing the cause of death by study group (Table 5.1.1.4) a striking
difference can be noticed. For the southern non-First Nation group 54.5% of
those women who died with a diagnosis of breast cancer, died from breast
cancer. The northern non-First Nation and southern First Nation groups had
similar distributions. Conversely 90.5% of those women with breast cancer in
the northern First Nation group who died from breast cancer.
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Table 5.1.1.5 - Distribution of death among breast cancer patients from
breast cancer and all.causes by study group and TNM stage, 1970-1995
Study Group TNM Death from Death from Proportion of Breast
Stage Breast Cancer all causes Cancer Deaths
Northern FN I 3 3 100.0%
II 9 11 81.8%
III 4 4 100.0%
IV 2 2 100.0%
Total 18 20 90.0%
Northern Non-FN I 2 6 33.3%
II 16 26 61.5%
III 2 2 100.0%
IV 1 3 33.3%
Total 21 37 56.8%
Southern FN I 2 5 40.0%
II 20 31 64.5%
III 4 7 57.1%
IV 5 7 71.4%
Total 31 50 62.0%
Southern Non-FN I 613 1718 35.7%
II 1597 2827 56.5%
III 459 655 70.1%
IV 530 655 80.9%
Total 3199 5855 54.6%
FN = First Nation
Table 5.1.1.5 describes the distribution of deaths of those women who were
diagnosed with breast cancer by study group and stage. For the southern First
Nation and southern non-First Nation groups the pattern of distribution is as
expected with the worse the stage of disease at diagnosis, the more likely one
dies from the underlying cancer, in this case cancer of the breast. The two
northern study groups however, have a different distribution in comparison to
the south. In the northern First Nation group for TNM stages I, II, and IV, 100%
of those women who died with a breast cancer diagnosis, actually died from
breast cancer. Of those that died with a diagnosis at TNM stage II, 81.8% died
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from breast cancer. In the northern non-First Nation group 33.3% of the
deaths were attributable to breast cancer among the TNM stage I and IV
diagnoses. Of those diagnosed at TNM stage II, 61.5% of the deaths were
attributable to breast cancer. AU of the deaths of those women diagnosed at
TNM stage III were attributable to breast cancer.
Table 5.1.1.6 - Distribution of deaths among breast cancer patients from
breast cancer and aUcauses bX study sroup and ase, 1970-1995
Study Group Age Group Death from Death from Proportion of Breast
~Years~ Breast Cancer aU causes Cancer Deaths
Northern FN 14 to 39 3 4 75.0%
40 to 49 3 3 100.0%
50 to 64 5 6 83.3%
65 and above 8 8 100.0%
Total 19 21 90.5%
Northern Non-FN 14 to 39 4 5 80.0%
40 to 49 8 12 66.7%
50 to 64 8 11 72.7%
65 and above 7 19 36.8%
Total 27 47 57.4%
Southern FN 14 to 39 10 10 100.0%
40 to 49 6 10 60.0%
50 to 64 7 13 53.8%
65 and above 10 20 50.0%
Total 33 53 62.3%
Southern Non-FN 14 to 39 220 276 79.7%
40 to 49 482 631 76.4%
50 to 64 1256 1882 66.7%
65 and above 1494 3548 42.1%
Total 3452 6337 54.5%
FN = First Nation
Table 5.1.1.6 describes the distribution of the deaths of those women
diagnosed with breast cancer by study group and age. An interesting pattern
is seen here amongst aU the study groups. The younger age-groups have a
higher proportion of deaths attributable to breast cancer in comparison to the
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older age- groups. In the northern First Nation group however, the
percentage of deaths attributable to breast cancer is high (75% or more) for
all four age-groups.
5.1.2 Breast Cancer Survival 1970 to 1995
The crude survival for breast cancer was calculated using the Kaplan Meier
method. Two end points for survival were used;
1) death from all causes and; 2) death from breast cancer.
Figure 5.1.2.1 - Survival curves of breast cancer patients by study group
(death from all causes) 1970 - 1995
_ Northern First
Nation
.. Northern Non-
First Nation
- Southern First
Nation
- Southern Non-
First Nation
Follow-up Time (Years)
Figure 5.1.2.1 shows the probability of survival over time (Kaplan Meier
Curves), where time zero is the time of diagnosis. By looking at the curves
alone the four study groups have a similar survival experience over the first
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five years after diagnosis. The northern First Nation group had a five-year
survival rate of 61%. While the northern non-First Nation group had a survival
rate of 59%. The southern First Nation group had a five-year survival of 60%.
The comparison group, the southern non-First Nation group, had a five-year
survival rate of 66%. Using the Log Rank test to compare the survival
distribution between the four study groups, the four study groups are found to
be not significantly different (p=0.61 ) where the end point is death from all
causes.
Figure 5.1.2.2 - Survival curves of breast cancer patients by study group
(death from breast cancer) 1970 - 1995
1.o~-------------------,
_ Northern First
Nation
- Southern Non-
First Nation
- Southern First
Nation
.. Northern Non-
First Nation
I.
I
" I
fl._._
1S10s
,s..
ill-
fI-
~~.
'l--\~, .
.-\·~·L'-7"l
ii
::-
'a
~ 2. i
i
ll"5E
2: 0.0 11IIo----_-- -----... --_---.1.
o
FollolJl.l-up Time (YeafS)
Figure 5.1.2.2 displays the Kaplan Meier survival curves for the four study
groups using death from breast cancer as the end point. In this instance the
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four curves have a different pattern in relation to one another compared to
the survival curves calculated using death from all causes as the end point
(Figure 5.1.2.1). As expected, the survival for the northern First Nation group
is worse in comparison to the other study groups. This is to be expected as
table 5.1.1.4 showed 90.5% of those women in the northern First Nation group
who died with a diagnosis of breast cancer died of breast cancer. For the
other three study groups, 62.3% or less died from breast cancer. The 5 year
survival rate for each study group is as follows: northern First Nation 67%,
northern non-First Nation 71 %, southern First Nation 69%, southern non-First
Nation n%. When the end point is death from breast cancer, there was a
significant difference in the survival distribution between the four study
groups (p =0.02, Log-rank test).
5.1.3 Cox Proportional Hazards Model
Univariate or crude survival analysis and multivariate or adjusted
survival are presented here. Comparison of crude and adjusted survival is
useful as crude survival was used to calculate cancer survival in previous
Saskatchewan studies. As mentioned earlier, the authors of the previous
study on this population suggest an examination of survival adjusting for
factors such as stage of disease at diagnosis and age.
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Table 5.1.3.1 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model,breast cancer 1970-95 ~death from all causes)
Model Variable RR 95% C.1.
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.28
1.07
1.12
0.83 - 1.96
0.80 - 1.42
0.86 - 1.48
I?-value
0.26
0.65
0.38
Age + Study Group Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.04
1.00
1.65
1.36
1.42
1.03 - 1.04
1.07 - 2.53
1.02 - 1.82
1.09 - 1.87
< 0.0001
0.0011
0.02
0.0104
Stage + Study Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.64
4.22
9.87
1.00
1.25
0.97
0.91
1.55-1.74
3.85 - 4.62
8.99 - 10.84
0.81 - 1.94
0.70 - 1.35
0.69 - 1.20
< 0.0001
< 0.0001
< 0.0001
0.32
0.87
0.51
0.072
0.24
0.20
< 0.0001
< 0.0001
< 0.0001
< 0.00011.03 - 1.04
1.60 - 1.81
3.76 - 4.50
8.22 - 9.91
1.04
1.00
1.70
4.11
9.03
Age + Stage + Study Age
Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN 1.00
Northern FN 1.50 0.97 - 2.32
Northern Non-FN 1.22 0.88 - 1.68
Southern FN 1.20 0.91 - 1.58
FN =First Nation, RR =Relative Risk, C.1. =Confidence Interval
Table 5.1.3.1 displays the results of the Cox's proportional hazards model
analysis. The results from the univariate (crude) and multivariate (adjusted)
Cox's model is presented where the end point for survival is death from all
causes. Four models are presented here. Each model is necessary in order to
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asses the influence of covariates on the relative risk of dying of breast cancer
for each study group in comparison to the reference group, the southern non-
First Nation group. The main interest here is the comparison of survival
distribution between study groups. The first model, a univariate model, has
study group alone in the model. With a relative risk greater than one the
northern First Nation, northern non-First Nation and southern First Nation
groups have a worse prognosis for breast cancer in comparison to the southern
non-First Nation group. It is very important to note however that these
relative risk estimates are not statistically significant and therefore these
relative risk estimates may occur by chance alone. Examining the second
model (Age and Study Group in the model) age is shown to be a strong
predictor of survival. This is seen by the tight 95% confidence interval about
the relative risk for age (1.04) and the highly significant p-value (p < 0.0001).
The relative risk of age can be interpreted as follows. For a ten year increase
in age, breast cancer patients are 1.48 times more likely to die of aU causes
(1.48 = 1.041°). In comparison to the southern non-First Nation group, aU
other three groups have increased risk of dying from breast cancer. This is
indicated by the statistically significant relative risks greater than one. The
third model examines TNM stage and study group. Here TNM stage is shown
to be a strong predictor of survival with highly significant p-values for stages
II, III, and IV in comparison to the reference group, TNM stage I. After
controlling for staging none of the study groups are significantly different
from the southern non-First Nation group. The final model contains study
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group, stage, and age. The final model presents the stage and age adjusted
relative risk for each study group in comparison to the southern non-First
Nation group. In this model both age at time of diagnosis and stage of disease
at time of diagnosis are taken into account when calculating the relative risk
of dying after a diagnosis of breast cancer. None of the three study groups,
northern First Nation, northern non-First Nation, and southern First Nation are
statistically different in comparison to the southern non-First Nation study
group.
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Table 5.1.3.2 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model, breast cancer 1970-95 (death from breast canceq
Model Variable RR 95% C.I.
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.94
1.11
1.23
1.24 - 3.05
0.76 - 1.62
0.87 - 1.74
p-value
0.004
0.59
0.23
Age + Study Group Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.01
1.00
2.06
1.18
1.30
1.00 - 1.01
1.31 - 3.23
0.81 - 1.73
0.92-1.83
< 0.0001
0.0017
0.39
0.13
2.33 - 2.80 < 0.0001
6.69 - 8.51 < 0.0001
17.28 - 21.97 < 0.0001
Stage + Study Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
2.55
7.54
19.48
1.00
1.76
1.01
0.91
1.11 - 2.81
0.66 - 1.55
0.64 - 1.30
0.016
0.96
0.62
2.34 - 2.81 < 0.0001
6.67 - 8.49 < 0.0001
17.04 - 21.68 < 0.0001
0.013
0.84
0.79
0.00091.00 - 1.011.00
1.00
2.56
7.52
19.22
Age + Stage + Study Age
Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN 1.00
Northern FN 1.81 1.14 - 2.87
Northern Non-FN 1.05 0.68 - 1.61
Southern FN 0.95 0.67 - 1.36
FN = First Nation, RR = Relative Risk, C.1. = Confidence Interval
Table 5.1.3.2 displays the results of the Cox's proportional hazards model
analysis, where the end point is death from breast cancer. This analysis
describes the relative risks of dying from breast cancer for each study group
in comparison to the southern non-First Nation group. The relative risk
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described here is calculated using the end point for survival as death from
breast cancer. In the first model with study group alone, the northern First
Nation group is found to have a 1.94 times greater risk of dying of breast
cancer in comparison to the southern non-First Nation group. The risk of
dying from breast cancer for the northern non-First Nation and southern First
Nation groups in comparison to the southern non-First Nation group are not
significantly different. From the second and third models, age at time of
diagnosis and stage at time of diagnosis are both found to be statistically
significant predictors of survival (p<O.0001). The final model shows northern
First Nation women diagnosed with breast cancer have 1.8 times greater
probability of dying of breast cancer in comparison to southern non-First
Nation women, where the end point is death from breast cancer (p = 0.01).
The two other study groups (northern non-First Nation and southern First
Nation) did not show a significantly different risk of breast cancer deaths in
comparison to the southern non-First Nation group. It is interesting to
compare the relative risk for northern First Nation in model one (study group
alone) and model four (study group +age + stage) to see the effect of
adjusting for age and stage at time of diagnosis. In both models the northern
First Nation group have a statistically significant relative risk in comparison to
the southern non-First Nation group, however the strength of relative risk
does change. The relative risk for the northern First Nation group is slightly
lower when taking into account stage and age. As the 95% confidence interval
in the stage and age adjusted survival model is tighter than the 95%
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confidence interval for the non-adjusted model, it can be said that the
relative risk for the stage and age adjusted model is more precise.
5.1.4 Cox Proportional Hazards Model - Survival Curves
In addition to calculating the adjusted relative risks, adjusted survival
curves can also be obtained from Cox's proportional hazards model. The
survival curves for the final model (age, stage, and study group) is presented
below. Figures 5.1.4.1 to 5.1.4.4 are the age and stage adjusted survival
curves, where the end point is death from all causes. The pattern for survival
for each study group is consistent after adjusting for stage and age. The
northern First Nations group has the worst survival pattern followed by the
southern First Nation and northern non-First Nation groups. The best survival
pattern is seen consistently in the southern non-First Nations group. The
pattern of distribution between the four study groups remains similar for each
TNM stage of disease. Figures 5.1.4.5 to 5.1.4.8 examine and compare the
cumulative survival pattern for each study group controlling for stage and
age, where the end point is death for breast cancer. Here there is a change
in the pattern of survival in comparison to the previous analysis where the
end point was death from aU causes. The northern First Nation group
experiences noticeably worse survival in comparison to the three other study
groups, however, the three other study groups (northern non-First Nations,
southern First Nations, and southern non-First Nations) all have a very
comparable survival pattern. The southern First Nation group experience the
best survival followed by the southern non-First Nation group and the
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northern non~First Nation group. The difference between these three groups
is very small however.
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Figure 5.1.4.1 - Age adjusted survival from cancer of the Breast,
TNM Stage I (death from all causes) 1970 - 1995
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Figure 5.1.4.2 - Age adjusted survival from cancer of the Breast,
TNM Stage II (death from all causes) 1970 - 1995
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Figure 5.1.4.3 - Age adjusted survival from cancer of the Breast,
TNM Stage III (death from all causes) 1970 - 1995
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Figure 5.1.4.4 - Age adjusted survival from cancer of the Breast,
TNM Stage IV (death from aU causes) 1970 - 1995
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Figure 5.1.4.5 - Age adjusted survival from cancer of the Breast,
TNM Stage I (death from breast cancer) 1970 - 1995
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Figure 5.1.4.6 - Age adjusted survival from cancer of the Breast,
TNM Stage II (death from breast cancer) 1970 - 1995
1.01I,r----------------------,
_ Northern Non-
First Nation
- Southern Non-
First Nation
_ Northern First
Nation
- Southern First
Nation
2S15105
~
.~
~ .2
41
~
IQ
:;
E
~ 0.0_--_-__--__--_--_--_
o
Follow-up Time (Years)
57
Figure 5.1.4.7 - Age adjusted survival from cancer of the Breast,
TNM Stage III (death from breast cancer) 1970 - 1995
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Figure 5.1.4.8 - Age adjusted survival from cancer of the Breast,
TNM Stage IV (death from breast cancer) 1970 - 1995
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5.2 Cancer of the Cervix
The International Classification of Diseases for Oncology (ICDO) codes for
cancer of the cervix used were; C180 toC180.9.
5.2.1 Distribution of Cervical Cancer Cases
Table 5.2.1.1 - Distribution of Cervical Cancer by study group and TNM stage,
1980-1995
Studx: Groue Stase Total
I II III IV
Northern FN 6 6 6 18
(33.3%) (33.3%) (33.3%) (100.0%)
Northern Non-FN 4 4 2 1 11
(36.4%) (36.4%) (18.2%) (9.1%) (100.0%)
Southern FN 53 22 24 7 106
(50.0%) (20.8%) (22.6%) (6.6%) (100.0%)
Southern Non-FN 298 105 98 31 532
(56.0%) (19.7%) (18.4%) (5.8%) (100.0%)
Total 361 137 130 39 667
(54.1%) (20.5%) (19.5%) (5.8%) (100.0%)
FN = First Nation
96 cases with missing stage data
As seen in Table 5.2.1.1, the total number of cervical cancer cases was small
in the northern study groups. The northern First Nation group had a total of
18 cases and the northern non-First Nation group with a total of 11 cases.
When comparing the proportions of cases over the four TNM stages by study
group it is important to keep in mind that the number of cases are small in
the north and results from this analysis should be interpreted with caution as
a small number of cases may not reflect true differences or trends.
Examining the proportional distribution, it is noteworthy that of those women
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diagnosed with cervical cancer in the southern non-First Nation group and the
southern First Nation group, 50% or more were diagnosed at TNM stage I. In
contrast, for the northern First Nation group 33.3% were diagnosed at TNM
stage I. In the northern non-First Nation group 36.4% were diagnosed at TNM
stage I. Again it is important to remember that the number of cases in the
north are quite small and therefore interpretation of these proportions should
not necessarily carry much weight. It is interesting to note however that the
age-standardized incidence rates of cervical cancer among all Saskatchewan
First Nations and First Nations on reserve in northern Saskatchewan since 1980
are higher than the rate for the province as a whole(53). The total number of
diagnoses from 1980 to 1995 for cervical cancer was 715 yet 667 had staging
information. All of these 96 cases with missing stage data were in the south.
Table 5.2.1.2 - Distribution of Cervical Cancer by study group and age, 1980-
1995
Study Group A~e Group tiears) Total
18 to 34 35 to 49 50 to 69 708: above
Northern FN 3 8 6 1 18
(16.7%) (44.4%) (33.3%) (5.6%) (100.0%)
Northern Non-FN 4 4 2 1 11
(36.4%) (36.4%) (18.2%) (9.1%) (100.0%)
Southern FN 30 45 23 13 111
(27.0%) (40.5%) (20.7%) (11.7%) (100.0%)
Southern Non-FN 122 177 162 114 575
(21.2%) ~30.8%) (28.2%) ~19.8%) (100.0%)
Total 159 234 193 129 715
(22.2%) (32.7%) (27.0 %) (18.0%) (100.0%)
FN = First Nation
Table 5.2.1.2 explores the distribution of age by study group. As age is being
examined it is important to remember the demography of the study
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population. The northern First Nation population is much younger than the
other populations. Recall the information on the age compositions of these
populations presented in section 5.1. Looking at the highlights of this table it
can be observed that for all the study groups over 50% of those women
diagnosed with cervical cancer are diagnosed at the age of 49 or younger.
The southern non-First Nation groups proportional distribution of cervical
cancer is more evenly distributed across the 4 age-groupings in comparison to
the three other study groups.
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Table 5.2.1.3 - Distribution of Cervical Cancer by study group, TNM stage, and
age, 1980-1995
Study Group Ase Group <years) Total
Stase 18 to 34 35 to 49 50 to 69 706: above
Northern FN I 2 2 2 0 6
(66.7%) (25.0%) (33.3%) (0.0%) (33.3%)
II 1 1 3 1 6
(33.3%) (12.5%) (50.0%) (100.0%) (33.3%)
III 0 5 1 0 6
(0.0%) (62.5%) (16.7%) (0.0%) (33.3%)
IV 0 0 0 0 0
(0.0%) (0.0%) (0.0%) (0.0%) (0.0%)
Total 3 8 6 1 18
(100.0%) (100.0%! pOO.O%~ (100.0%! pOO.O%'
Northern Non- 2 2 0 0 4
FN (50.0%) (50.0%) (0.0%) (0.0%) (36.4%)
II 1 1 1 1 4
(25.0%) (25.0%) 50.0%) (100.0%) (36.4%)
III 1 1 0 0 2
(25.0%) (25.0%) (0.0%) (0.0%) (18.2%)
IV 0 0 1 0 1
(0.0%) (0.0%) (50.0%) (0.0%) (9.1%)
Total 4 4 2 1 11
pOO.O%' pOO.O%! (100.0%! (100.0%) (100.0%!
Southern FN 22 22 9 0 53
(73.3%) (50.0%) (39.1%) (0.0%) (50.0%)
II 3 11 4 4 22
(10.0%) (25.0%) (17.4%) (33.3%) (20.8%)
III 5 6 7 6 24
(16.7%) (13.6%) (30.4%) (50.0%) (22.6%)
IV 0 2 3 2 7
(0.0%) (4.5%) (13.0%) (16.7%) (6.6%)
Total 30 41 23 12 106
(100.0%' (100.0%) pOO.O%~ (100.0%~ (100.0%~
Southern Non- 87 111 66 34 298
FN (75.0%) (66.5%) (43.4%) (35.1%) (56.0%)
II 11 27 37 30 105
(9.5%) (16.2%) (24.3%) (30.9%) (19.7%)
III 18 24 31 25 98
(15.5%) (14.4%) (20.4%) (25.8%) (18.4%)
IV 0 5 18 8 31
(0.0%) (3.0%) (11.8%) (8.2%) (5.8%)
Total 116 167 152 97 532
(100.0%) ~100.0%) ~100.0%) (100.0%) (100.0%)
FN = First Nation
62
In Table 5.2.1.3 the distribution of cervical cancer is presented by age and
TNM stage for each study group. Some highlights from this table are as
follows. For aU study groups the largest proportion of cases for each age·
group occurred at TNM stage II or less. That is to say that the most diagnoses
of cervical cancer occur at an early stage for aU age-groups. For the southern
non-First Nation group the largest proportion of cases were diagnosed at TNM
stage I for each age-group.
Table 5.2.1.4 - Distribution of deaths among cervical cancer patients from
cervical cancer and all causes by study sroup, 1980-1995
Study Group Death from Death from Proportion of Cervical
Cervical Cancer aU causes Cancer Deaths
Northern FN
Northern Non-FN
Southern FN
Southern Non-FN
Total
FN = First Nation
4 11 36.4%
3 4 75.0%
~ ~ ~.7%
138 254 54.3%
181 323 56.0%
Table 5.2.1.4 presents the distribution of cervical cancer deaths from 1980 to
1995 by study group. For the southern non-First Nation group 54.3% of
cervical cancer patients, died of cervical cancer. In the northern First Nation
group 36.4% of cervical cancer patients, died of cervical cancer. In the
northern non-First Nation group, 75% of the cervical cancer patients deaths
were due to cervical cancer, this group however had very few cases during
this time frame. In the southern First Nation group 66.7% of cervical cancer
patients died of cervical cancer.
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Table 5.2.1.5 - Distribution of deaths from Cervical cancer and all causes by
stud:t sroup and Stase, 1980-1995
Study Group Stage Death from Death Proportion of Cervical
Cervical Cancer from all Cancer Deaths
causes
Northern FN I 1 2 50.0%
II 2 6 33.3%
III 1 3 33.3%
IV
Total 4 11 36.4%
Northern Non-FN I
II 1 2 50.0%
III 1 1 100.0%
IV 1 1 100.0%
Total 3 4 75.0%
Southern FN I 7 12 58.3%
II 11 16 68.8%
III 12 17 70.6%
IV 5 7 71.4%
Total 35 52 69.2%
Southern Non-FN I 18 68 26.5%
II 35 65 53.8%
III 48 70 68.6%
IV 26 29 89.7%
Total 127 232 54.7%
FN = First Nation, "-" = no cases observed
Table 5.2.1.5 describes the proportion of deaths from cervical cancer in
comparison to all causes by TNM stage and study group. As one would expect
the worse the TNM stage at the time of diagnosis the higher the proportion of
deaths attributable to cervical cancer. In the southern non-First Nation group
89.7% of those women who died with a cervical cancer diagnosis, died from
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cervicaL cancer. This is in contrast to 36.5% of those diagnosed at TNM stage I
actually died of cervical cancer compared to aU deaths. This points to the
conclusion that early diagnosis can perhaps lead to a better chance of
survivaL. In other words, if one is diagnosed earLy they may die of other
causes before they die of cervical cancer.
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Table 5.2.1.6 - Distribution of deaths from cervical cancer and aU causes by
study groue and age, 1980-1995
Study Group Age Death from Death from Proportion of
Group Cervical aU causes Cervical Cancer
!yearsl Cancer Deaths
Northern FN 18 to 34 1 1 100.0%
35 to 49 2 4 50.0%
50 to 69 5
70 and 1 1 100.0%
above
Total 4 11 36.4%
Northern Non-FN 18 to 34 1 1 100.0%
35 to 49
50 to 69 2 2 100.0%
70 and 1
above
Total 3 4 75.0%
Southern FN 18 to 34 5 5 100.0%
35 to 49 20 24 83.3%
50 to 69 4 13 30.8%
70 and 7 12 58.3%
above
Total 36 54 66.7%
Southern Non-FN 18 to 34 15 16 93.8%
35 to 49 27 44 61.4%
50 to 69 54 97 55.7%
70 and 42 97 43.3%
above
Total 138 254 54.3%
FN = First Nation, "-" = no cases observed
Table 5.2.1.6 describes the distribution deaths from cervical cancer among
all those women that died with a diagnosis of cervical cancer by age-group
and study group. An interesting distribution of deaths is in the age-group 18
to 34 in the southern non-First Nation group. In this group 93.8% of those
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women who died with a cervical cancer diagnosis died from cervical cancer.
In the southern First Nation group for the 18 to 34 age-group, 100% of those
women diagnosed with cervical cancer who died, died of cervical cancer. For
the 35 to 49 year age-group 83.3% of those southern First Nation women that
died, died from cervical cancer. The number of deaths in the two northern
study groups is quite small and it would be inappropriate to comment on the
distribution of deaths for these study groups.
5.2.2 Cervical Cancer Survival 1980 to 1995
The crude survival for cervical cancer was calculated using the Kaplan Meier
method. Two end points for survival were used;
1) death from all causes and; 2) death from cervical cancer.
67
Figure 5.2.2.1 - Survival from cancer of the Cervix (death from aU causes)
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Figure 5.2.2.1 shows the proportion of women who remain alive over time,
where time zero is the time of diagnosis. By looking at the curves alone the
northern First Nation and southern First Nation study groups have a similar
survival experience over the first five years after diagnosis. The survival
curves for the northern First Nation, northern non-First Nation, and the
southern First Nation groups are jagged in appearance as the number of cases
for these groups is small. The northern First Nation group had a five-year
survival rate of 52%. The northern non-First Nation group had a five-year
survival rate of 62%. The southern First Nation group had a five year-survival
rate of 50%. The comparison group, the southern non-First Nation group, had
a five-year survival rate of 61%. Using the Log Rank test to compare the
survival between the four study groups, the four study groups are found to be
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not significantly different (p = 0.08) where the end point is death from all
causes.
Figure 5.2.2.2 - Survival from cancer of the Cervix (death from cervical
cancer) 1980 - 1995
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Figure 5.2.2.2 displays the Kaplan Meier survival curves for the four study
groups using death from cervical cancer as the end point. In this instance the
four curves have a similar pattern in relation to one another. The long term
survival for all four study groups is better in comparison to the analysis using
death from all causes as the end point. The southern First Nation group shows
a noticeably worse survival pattern compared to the other study groups. The
five-year survival rate for each study group is as follows: northern First
Nation 69%, northern non-First Nation 69%, southern First Nation 63%,
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southern non-First Nation 73%. The Log Rank test comparing the four study
groups survival yields a p value of 0.13 and thus when the end point is death
from cervical cancer the four study groups survival are not significantly
different.
5.2.3 Cox Proportional Hazards Model
Similar to the analysis for breast cancer, a Cox's proportional hazards model
has been used to compare the relative risk of dying for those diagnosed with
cervical cancer. Two analyses have been undertaken here. The first one uses
death from aU causes as the end point. The second one uses death from
cervical cancer as the end point.
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Table 5.2.3.1 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model, cervical cancer 1980-95 ~death from aU causes)
Model Variable R. R. 95% C.1.
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.67
0.84
1.38
0.91 - 3.07
0.31 - 2.25
1.02 - 1.86
e-value
0.095
0.723
0.034
Age + Study Group Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.05
1.00
1.97
1.34
1.85
1.04 - 1.05
1.07 - 3.61
0.50 - 3.61
1.37 - 2.50
< 0.0001
0.028
0.564
0.0001
Stage + Study Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
3.82
6.51
16.13
1.00
1.40
0.61
1.18
2.81-5.18
4.78 - 8.88
10.67 - 24.39
0.76 - 2.57
0.23 - 1.65
0.87 - 1.60
< 0.0001
< 0.0001
< 0.0001
0.283
0.334
0.294
0.087
0.913
0.029
< 0.0001
< 0.0001
< 0.0001
< 0.0001
1.96 - 3.71
3.68 - 6.92
6.18 - 14.56
1.02 - 1.041.03
1.00
2.70
5.05
9.49
Age + Stage + Study Age
Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN 1.00
Northern FN 1.71 0.93 - 3.15
Northern Non-FN 0.95 0.35 - 2.56
Southern FN 1.41 1.04 - 1.92
FN = First Nation, RR = Relative Risk, C.1. = Confidence Interval
Table 5.2.3.1 dispLays the resuLts of the Cox proportional hazard modeL
analysis for those women diagnosed with cervical cancer where the end point
for survivaL is death from aU causes. The first modeL (univariate or
unadjusted) shows southern First Nation women diagnosed with cervical
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cancer have 1.38 times greater risk of dying of cervical cancer in comparison
to southern non-First Nation women, where the end point is death from all
causes. This difference is statistically significant, p = 0.034. The second
model (study group and age) shows the southern First Nation group to have a
statistically significant relative risk in comparison to the southern non-First
Nation group when adjusting for age at time of diagnosis. Age is shown to be
highly significant (p < 0.0001) as a predictor of survival. The third model
(stage and study group) shows all stage to be highly statistically significantly
different from stage I and the relative risk for each TNM stage (II, III, IV) is
progressively worse. This would mean that the worse the stage at time of
diagnosis, the greater the relative risk of dying. The final model shows both
stage and age at time of diagnosis are statistically significant predictors of
survival (p<0.0001). For the southern First Nation group the relative risk of
dying from any cause is significant in comparison to the southern non-First
Nation group (p = 0.03). Southern First Nation women diagnosed with cervical
cancer have 1.41 times greater risk of dying of cervical cancer in comparison
to southern non-First Nation women, where the end point is death from
cervical cancer. Compared to the non-adjusted or univariate model, the
relative risk for the southern First Nation group is slightly greater when
adjusting for both stage and age at time of diagnosis.
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Table 5.2.3.2 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model, cervical cancer 1980-95 (death from cervical cancer)
Model Variable R. R. 95% C.I. p-value
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.01
1.06
1.53
0.37 - 2.72
0.34 - 3.33
1.06 - 2.22
0.990
0.921
0.025
Age + Study Group Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.03
1.00
1.14
1.41
1.84
1.02 - 1.04
0.42 - 3.09
0.45 - 4.43
1.26 - 2.68
< 0.0001
0.793
0.559
0.002
Stage + Study Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
5.96
11.32
33.32
1.00
0.82
0.72
1.32
3.70 - 9.61
7.11 -18.04
19.53 - 56.84
0.30 - 2.23
0.23 - 2.27
0.91 - 1.93
< 0.0001
< 0.0001
< 0.0001
0.695
0.576
0.148
0.805
0.737
0.0970
0.0310
< 0.0001
< 0.0001
< 0.0001
1.00 - 1.02
3.23 - 8.61
6.48 - 16.67
15.62 - 48.00
1.01
1.00
5.27
10.39
27.38
Age + Stage + Study Age
Group TNM Stage
I
II
III
IV
Study Group
Southern Non-FN 1.00
Northern FN 0.88 0.32 - 2.40
Northern Non-FN 0.82 0.26 - 2.60
Southern FN 1.38 0.94 - 2.01
FN =First Nation, RR =Relative Risk, C.1. =Confidence Interval
Table 5.2.3.2 displays the results of the Cox's model where the end point for
survival is death from cervical cancer. The first model shows that southern
First Nation women diagnosed with cervical cancer have 1.53 times greater
risk of dying of cervical cancer in comparison to southern non-First Nation
73
women, where the end point is death cervical cancer (p = 0.025). In the
second model, the southern First Nation group again is found to have a
statistically significant relative risk in comparison to the southern non-First
Nation group (relative risk = 1.84 P = 0.002). Age is found to be a significant
predictor of survival when controlling for study group. Model three shows
that when controlling for study group the relative risk from dying from
cervical cancer at stage II, III, and IV are greater than dying from cervical
cancer when diagnosed at TNM stage I. The final model (stage, age and study
group) shows that the northern First Nation and the northern non-First Nation
groups have a relative risk of less than one, meaning that their e risk of dying
from cervical cancer is better in comparison to the southern non-First Nation
group. It is important to note here that both of these relative risks are not
statistically significant. Southern First Nation women diagnosed with cervical
cancer have 1.38 times greater risk of dying of cervical cancer in comparison
to southern non-First Nation women, where the end point is death from
cervical cancer. Here again however, this relationship is shown to be not
statistically significant. Comparing the non-adjusted model to the adjusted
model, the southern First Nation group goes from having a significant relative
risk to a non-significant relative risk. One must be aware here that the
adjusted model allows for a better analysis of survival for each study group as
both age and stage (strong predictors of survival on their own) are included in
the calculation of the relative risk estimate.
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5.2.4 Cox Proportional Hazards Model - Survival Curves
In addition to calculating the adjusted relative risks, the Cox's model also
produces survival curves adjusting for covariates. The survival curves for the
final model (age, stage, and study group) is presented below. Figures 5.2.4.1
to 5.2.4.4 present the age and stage adjusted survival curves for cervical
cancer, where the end point is death from aU causes. The consistent pattern
seen here shows the two non-First Nation groups to have very similar survival
patterns. Both of these study groups show consistently better survival in
comparison to the two Fist Nation groups. The northern First Nation group
consistently has the worst survival for each TNM stage. The southern First
Nation group has a similar survival pattern to the northern First Nation group
and is slightly better off in survival.
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Figure 5.2.4.1 - Age adjusted survival from cancer of the Cervix,
TNM Stage I (death from aU causes) 1980 - 1995
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Figure 5.2.4.2 - Age adjusted survival from cancer of the Cervix,
TNM Stage II (death from all causes) 1980 - 1995
1'OIPr--------------------.,
s 10 15
_ Northern First
Nation
.. Northern Non-
First Nation
- Southern First
Nation
- Southern Non-
First Nation
Follow-up Time (YealS)
76
Figure 5.2.4.3 - Age adjusted survival from cancer of the Cervix,
TNM Stage III (death from aU causes) 1980 - 1995
_ Northern First
Nation
- Southern Non-
First Nation
- Southern First
Nation
... Northern Non-
First Nation
1S10
1'01lr----------------------,
"iii
:=-
':§:
~ 2
41
:::>
~
:;
E
c30.0.L- --===3=~..............-----l
o
Fol!olAl-up Time (Years:)
Figure 5.2.4.4 - Age adjusted survival from cancer of the Cervix,
TNM Stage IV (death from aU causes) 1980 - 1995
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Figures 5.2.4.5 to 5.2.4.8 are the age and stage adjusted survival curves,
where the end point is death from cervical cancer. Here each figure
consistently shows the southern First Nation group with the worst survival.
This is followed by the southern non-First Nation group, the northern First
Nation group, and the northern non-First Nation group.
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Figure 5.2.4.5 - Age adjusted survival from cancer of the Cervix,
TNM Stage I (death from cervical cancer) 1980 - 1995
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Figure 5.2.4.6 - Age adjusted survival from cancer of the Cervix,
TNM Stage II (death from cervical cancer) 1980 - 1995
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Figure 5.2.4.7 - Age adjusted survival from cancer of the Cervix,
TNM Stage III (death from cervical cancer) 1980 - 1995
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Figure 5.2.4.8 - Age adjusted survival from cancer of the Cervix,
TNM Stage IV (death from cervical cancer) 1980 - 1995
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5.3 Cancer of the Colon and Rectum
The International Classification of Diseases for Oncology (ICDO) codes for
colorectal cancer used were; C18, C19.9,C20.9 and C21.0 to C21.8. The
analysis for colorectal cancer was done combining information for both sexes,
as the number of cases for each sex individually is quite small.
5.3.1 Distribution of Colorectal Cancer Cases
Table 5.3.1.1 - Distribution of Colorectal Cancer by study group and Dukes
stage, 1990-1995
Study Groue DukesStaae Total
A B C 0
Northern FN 5 7 1 13
(38.5%) (53.8%) (7.7%) (100.0%)
Northern Non-FN 2 4 6 1 13
(15.4%) (30.8%) (46.2%) (7.7%) (100.0%)
Southern FN 1 10 11 5 27
(3.7%) (37.0%) (40.7%) (18.5%) (100.0%)
Southern Non-FN 337 932 798 347 2414
(14.0%~ ~38.6%! ~33.1%} (14.4%) ~100.0%)
Total 340 951 822 354 2467
(13.8%) (38.5%) ~33.3%~ ~14.3%! (100.0%!
FN = First Nation
920 cases with missing stage data
Table 5.3.1.1 examines the distribution of colorectal cancer cases for each
study group by Dukes stage from 1990 to 1995. First it is important to note
that in both the northern study groups there are very few cases, 13 in each.
For the northern First Nation group there were no cases diagnosed at Dukes
stage A. In contrast 14% of those men and women diagnosed with colorectal
cancer were diagnosed at Dukes stage A in the southern non-First Nation
group. The distribution of Dukes stage B was similar across the four study
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groups with 38.5% for the northern First Nation group, 30.8% in the northern
non-First Nation group, 37.0% for the southern First Nations, and 38.6% for the
southern non-First Nation group. For the northern First Nation group the
largest percentage of cases were diagnosed at Dukes stage C.
Table 5.3.1.2 - Distribution of Colorectal Cancer by study group and age,
1990-1995
Stud~ Group Ase Group ~Years) Total
20 to 49 50 to 64 65 and
above
Northern FN 2 11 4 17
(11.8%) (64.7%) (23.5%) (100.0%)
Northern Non-FN 2 8 10 20
(10.0%) (40.0%) (50.0%) (100.0%)
Southern FN 4 18 25 47
(8.5%) (38.3%) (53.2%) (100.0%)
Southern Non-FN 180 660 2463 3303
~5.5%) (20.0%) ~74.6%) (100.0%)
Total 188 697 2502 3387
~5.6%) (20.6%) (73.9%) (100.0%)
FN = First Nation
In table 5.3.1.2 the proportion of colorectal cancer cases diagnosed from 1990
to 1995 by study group and age is presented. Here again before interpreting
the information here it is important to keep in mind the differing age
structure of the north versus the south of Saskatchewan. For the southern
non-First Nation group the highest percentage distribution of colorectal
cancer cases was in the age-group 65 and above, with 74.6% of men and
women diagnosed with colorectal cancer in this age-group. Similarly in the
southern First Nation and the northern non-First Nation groups, the highest
proportion of cases were in this oldest age-group. For the northern First
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Nation group the highest proportion of colorectal cancer diagnoses were in
the 50 to 64 age group.
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Table 5.3.1.3 - Distribution of Colorectal Cancer by study group, Dukes stage,
and aae, 1990-1995
Study Group Ase Group ~Years) TotaL
Dukes 20 to 49 50 to 64 65 and
Stase above
Northern FN A
B 2 2 1 5
(100.0%) (22.2%) (50.0%) (38.5%)
C 6 1 7
(66.7%) (50.0%) (53.8%)
D 1 1
~11.1%! (7.7%)
TotaL 2 9 2 13
(100.0%) ~100.0%) pOO.O%} (100.0%)
Northern Non-FN A 1 1 2
(16.7%) (16.7%) (15.4%)
B 1 2 1 4
(100.0%) (33.3%) (16.7%) (30.8%)
C 3 3 6
(50.0%) (50.0%) (46.2%)
D 1 1
~16.7%) (7.7%)
TotaL 1 6 6 13
(100.0%! (100.0%) (100.0%) (100.0%)
Southern FN A 1 1
(6.3%) (3.7%)
B 4 6 10
(44.4%) (37.5%) (37.0%)
C 1 5 5 11
(50.0%) (55.6%) (31.3%) (40.7%)
D 1 4 5
~50.0%) ~25.0%) (18.5%!
TotaL 1 9 16 27
~100.0%) (100.0%) (100.0%) (100.0%)
Southern Non-FN A 20 56 261 337
(13.9%) (11.0%) (14.8%) (14.0%)
B 55 190 687 932
(38.2%) (37.5%) (39.0%) (38.6%)
C 50 184 564 798
(34.7%) (36.3%) (32.0%) (33.1%)
D 19 77 251 347
(13.2%) (15.2%) (14.2%) (14.4%1
TotaL 144 507 1763 2414
(100.0%) (100.0%) (100.0%) (100.0%)
FN =First Nation, n " =no cases observed
84
Table 5.3.1.3 examines the distribution of colorectal cancer cases for both
sexes diagnosed between 1990 and 1995 by age and Dukes stage. For the two
northern groups it is important to note that the number of cases is small,
making interpretation difficult. In the 65 and above age-group for the
southern non-First Nation group, 39.0% of the colorectal diagnoses were
diagnosed at Dukes stage B. This was the highest percentage of cases for the
southern non-First Nations group. Similarly for the southern First Nation
group in the 65 and above age-group, 37.5% of the diagnoses were diagnosed
at Dukes stage B. For the northern non-First Nation group, half of those men
and women diagnosed with colorectal cancer in the age-group 65 and above
were diagnosed at Dukes stage C.
Table 5.3.1.4 - Distribution of deaths among colorectal cancer patients from
colorectal cancer and all causes by study group, 1990-1995
Study Group Death from Death from aU Proportion of Colorectal
colorectal cancer causes Cancer Deaths
Northern FN
Northern Non-FN
Southern FN
Southern Non-FN
Total
FN = First Nation
3 6 50.0%
7 11 63.6%
17 29 58.6%
1189 1893 62.8%
1216 1939 62.7%
Table 5.3.1.4 describes the distribution of deaths among those diagnosed with
colorectal cancer between 1990 and 1995 by study group. For all study groups
approximately half or more of those men and women who died with a
diagnosis of colorectal cancer, died from colorectal cancer. The lowest
proportion (50%) was in the northern First Nation group. The highest
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proportion of deaths attributable to colorectal cancer was in both the
northern non-First Nation group (63.6%) and the southern non-First Nation
group (62.8%). For the southern First Nation group, 58.6% of those women
and men who died with a colorectal cancer diagnosis, died from colorectal
cancer. It is difficult to ascertain whether the differences observed between
study groups are meaningful as the number of cases in the north are quite
few.
Table 5.3.1.5 - Distribution of deaths among colorectal cancer patients from
colorectal cancer and aU causes bystudy group and Sta~e, 1990-1995
Study Group Dukes Death from Death from Proportion of
Stage colorectal all causes Colorectal Cancer
cancer Deaths
Northern FN
Total
Northern Non-FN
Total
Southern FN
Total
Southern Non-FN
Total
FN =First Nation,
A
B
C 1 3 33.3%
D 1 1 100.0%
2 4 50.0%
A
B 1 1 100.0%
C 3 4 75.0%
D 1 1 100.0%
5 6 83.3%
A
B 1 3 33.3%
C 4 6 66.7%
D 4 5 80.0%
9 14 64.3%
A 36 105 34.3%
B 178 381 46.7%
C 347 507 68.4%
D 258 338 76.3%
819 1331 61.5%
.. -" = no cases observed
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Table 5.3.1.5 describes the distribution of those men and women diagnosed
with colorectal cancer between 1990 and 1995 who died either from
colorectal cancer or from another cause. Examining the southern non-First
Nation group, the expected pattern of distribution is seen. The worse the
stage (higher the stage) the higher the proportion of cases die of colorectal
cancer. Of those that died with a diagnosis of colorectal cancer at Dukes
stage D, 76.3% died from colorectal cancer. This was then followed by Dukes
stage C (68.4%), stage B (46.7%), and stage A (34.3%). A similar pattern was
seen in the southern First Nation group. The number of deaths in the two
northern groups was very small thus making interpretation difficult.
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Table 5.3.1.6 - Distribution of deaths among colorectal cancer patients from
colorectal cancer and aU causes by study group and age, 1990-1995
Study Group Age Death from Death from Proportion of
Group colorectal aU causes Colorectal Cancer
(Years1 cancer Deaths
Northern FN 50 to 64 2 4 50.0%
65 and 1 2 50.0%
above
Total 3 6 50.0%
Northern Non-FN 50 to 64 2 3 66.7%
65 and 5 8 62.5%
above
Total 7 11 63.6%
Southern FN 20 to 49 1 2 50.0%
50 to 64 7 10 70.0%
65 and 9 17 52.9%
above
Total 17 29 58.6%
Southern Non-FN 20 to 49 7 65 10.8%
50 to 64 83 305 27.2%
65 and 614 1523 40.3%
above
Total 704 1893 37.2%
FN = First Nation
Table 5.3.1.6 examines the distribution of those men and women who died
with a diagnosis of colorectal cancer between 1990 and 1995. For the
southern non-First Nation group the largest proportion of deaths attributable
to colorectal cancer was in the 65 and above age-group. In the southern First
Nation group the 20 to 39 age-group had the highest proportion of colorectal
cancer deaths but this was only one case and therefore must be interpreted
with caution. Also in this study group the 50 to 64 age-group had 70.0% of the
deaths attributable to colorectal cancer. AU deaths from colorectal cancer or
other causes occurred in the 50 to 64 and 65 and above age-groups in the two
northern study groups.
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Figure 5.3.2.1 - Survival from Colorectal cancer (death from all causes) 1990 -
1995
1) death from all causes and; 2) death from colorectal cancer.
The crude survival for colorectal cancer was calculated using the Kaplan-
Meier method. Two end points for survival were used;
Follow-up Time (Years)
Figure 5.3.2.1 shows the proportion of colorectal cancer patients who remain
alive over time, where time zero is the time of diagnosis. By looking at the
curves alone, the four study groups survival experience over the first five
years after diagnosis is quite different. The northern First Nation group had a
five-year survival rate of 56%. The northern non-First Nation group had a
survival rate of 39%. The southern First Nation group had a five-year survival
of 34%. The comparison group, the southern non-First Nation group, had a
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survival between the four study groups, the four study groups are found to be
five-year survival rate of 35%. Using the Log Rank test to compare the
Figure 5.3.2.2 - Survival from Colorectal cancer (death from colorectal
cancer) 1990 - 1995
not significantly different (p = 0.34) where the end point is death from all
Follo\Al-up Time (Years)
Figure 5.3.2.2 displays the Kaplan Meier survival curves for the four study
groups using death from colorectal cancer as the end point. In this instance
the four curves have a somewhat similar pattern in relation to one another.
The northern First Nation group only had 3 deaths and therefor the survival
curve is almost flat. The five-year survival rate for each study group is as
follows: northern First Nation 82%, northern non-First Nation 59%, southern
First Nation 55%, southern non-First Nation 52%. The 82% five-year survival
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rate for the northern First Nation group would seem high, but recall that only
4 of 13 cases died. The Log Rank test comparing the four study groups
survival yields a p value of 0.4861 and thus when the end point is death from
colorectal cancer the four study groups survival are not significantly different.
5.3.3 Cox Proportional Hazards Model
Similar to the analysis for breast cancer, a Cox's proportional hazards model
has been used to compare the relative risk of dying for those diagnosed with
cervical cancer. Two analyses have been undertaken here. The first one uses
death from all causes as the end point. The second one uses death from
colorectal cancer as the end point.
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Table 5.3.3.1 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model, colorectal cancer 1990-95 (death from aU causes)
Model Variable R.R. 95% C.1.
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
0.58
0.88
1.26
0.26 - 1.30
0.49 - 1.60
0.86 - 1.40
e-value
0.189
0.6n
0.237
Age + Study Group Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.03
1.00
0.79
1.08
1.40
1.02 - 1.03
0.35 - 1.75
0.60 - 1.96
0.96 - 2.05
< 0.0001
0.328
0.792
0.082
Stage + Study Group Dukes Stage
A
B
C
D
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
1.00
1.38
2.59
12.17
1.00
0.58
0.72
0.96
1.11 -1.72
2.10 - 3.20
9.70 - 15.26
0.22 - 1.55
0.32 - 1.60
0.56 - 1.66
0.0037
< 0.0001
< 0.0001
0.281
0.417
0.889
0.843
0.750
0.614
0.007
< 0.0001
< 0.0001
< 0.00011.03 - 1.04
1.09 - 1.68
2.18 - 3.33
10.n - 16.98
1.03
1.00
1.35
2.69
13.52
Age + Stage + Study Age
Group Dukes Stage
A
B
C
D
Study Group
Southern Non-FN 1.00
Northern FN 0.90 0.34 - 2.42
Northern Non-FN 0.88 0.39 - 1.96
Southern FN 1.15 0.67 - 1.99
FN =First Nation, RR =Relative Risk, C.1. =Confidence Interval
Table 5.3.3.1 displays the results of the Cox's proportional hazards model
analysis where the end point for survival is death from aU causes. Four
models are presented here. Each model is necessary in order to asses the
influence of covariates on the relative risk of dying of colorectal cancer for
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each study group in comparison to the reference group, the southern non-First
Nation group. The first model has study group alone in the model. With a
relative risk of less than one the northern First Nation and northern non-First
Nation groups have a better prognosis for colorectal cancer in comparison to
the southern non-First Nation group. The southern First Nation group has 1.26
times greater probability of dying of colorectal cancer in comparison to
southern non-First Nation group, where the end point is death from all causes.
Avery important note here is that these relative risks are not statistically
significantly different from the southern non-First Nation group and therefore
these differences could take place by chance alone. The second and third
models show age and Dukes stage to be strong predictors of colorectal cancer
survival controlling for study group. The final model showed similar results to
the first or crude model, where the northern First Nation and northern non-
First Nation groups both were protective in terms of relative risk in
comparison to the southern non-first Nation group. The southern First Nation
group had 1.15 times greater risk of dying of colorectal cancer in comparison
to southern non-First Nation group when controlling for both stage and age at
time of diagnosis, where the end point is death from all causes. All of these
relative risks were not significantly different from the southern non-First
Nation group.
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Model Variable R.R. 95% C.I. p-value
Table 5.3.3.2 - Univariate and Multivariate Relative Risks for Study Groups
from Cox's model, colorectal cancer 1990-95 (death from colorectal cancer)
Study Group alone Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
0.286
0.929
0.374
0.2n
0.888
0.719
0.1n
0.697
0.551
0.0015
< 0.0001
< 0.0001
< 0.0001
0.12 - 1.86
0.39 - 2.26
0.44 - 1.77
0.17 - 1.68
0.46 - 2.03
0.76 - 2.05
0.15 - 1.42
0.41 - 1.81
0.71 - 1.90
1.01 - 1.02
1.25 - 2.57
3.56 - 7.07
17.08 - 34.68
1.00
0.46
0.94
0.88
1.02
1.00
0.54
0.97
1.25
1.00
0.46
0.86
1.17
1.00
1.79
5.02
24.33
Age
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
Age + Study Group
Stage + Study Group Dukes Stage
A
B
C
D
Study Group
Southern Non-FN
Northern FN
Northern Non-FN
Southern FN
0.453
0.933
0.963
0.0017
< 0.0001
< 0.0001
< 0.00011.01 - 1.03
1.24 - 2.55
3.64 - 7.24
18.19 - 36.99
1.02
1.00
1.78
5.14
25.94
Age + Stage + Study Age
Group Dukes Stage
A
B
C
D
Study Group
Southern Non-FN 1.00
Northern FN 0.59 0.15 - 2.36
Northern Non-FN 1.04 0.43 - 2.51
Southern FN 0.98 0.49 - 1.98
FN =First Nation, RR =Relative Risk, C.1. =Confidence Interval
Table 5.3.3.2 displays the Cox's model for colorectal cancer where the end
point for survival is death from colorectal cancer. The first or un-adjusted
model shows similar results to the first model presented in table 5.3.3.1. The
northern First Nation and northern non-First Nation groups both had relative
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risks of less than one, meaning they had a better prognosis after being
diagnosed with colorectal cancer than those in the reference group, the
southern non-First Nation group. The southern First Nation group had 1.17
times greater probability of dying of colorectal cancer in comparison to
southern non-First Nation group, where the end point is death from colorectal
cancer. All of these relative risks were not statistically significantly different
from the southern non-First Nation group however. The last model (age,
stage and study group) showed a relative risk of less than one for both the
northern First Nation and southern First Nation groups. The northern non-
First Nation group had 1.04 times greater probability of dying of colorectal
cancer in comparison to southern non-First Nation group, where the end point
is death from colorectal cancer. None of these relative risks were statistically
significantly different from the southern non-First Nation group.
5.3.4 Cox Proportional Hazards Model - Survival Curves
In addition to calculating the adjusted relative risks, the Cox's model also
produces survival curves adjusting for covariates. The survival curves for the
final model (age, stage, and study group) is presented below. Figures 5.3.4.1
to 5.3.4.4 present the age and stage adjusted survival curves for colorectal
cancer, where the end point is death from all causes. The consistent pattern
seen here shows the two northern population groups to have very similar
survival patterns. The northern First Nation and northern non-First Nation
groups survival pattern are almost identical over the four Dukes stages. Both
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of these study groups show slightly better survival in comparison to the two
southern groups. The southern First Nation group consistently has the worst
survival for each Dukes stage. The southern non-First Nation group has a
similar survival pattern to the southern First Nation group and is slightly
better off in survival.
%
Figure 5.3.4.2 - Age adjusted survival from colorectal cancer,
Dukes Stage B (death from aU causes) 1990 - 1995
Figure 5.3.4.1 - Age adjusted survival from colorectal cancer,
Dukes Stage A (death from aU causes) 1990 - 1995
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Figure 5.3.4.4 - Age adjusted survival from colorectal cancer,
Dukes Stage D (death from all causes) 1990 - 1995
Figure 5.3.4.3 - Age adjusted survival from colorectal cancer,
Dukes Stage C (death from aU causes) 1990 - 1995
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Figure 5.3.4.6 - Age adjusted survival from colorectal cancer,
Dukes Stage B (death from colorectal cancer) 1990 - 1995
Figure 5.3.4.5 - Age adjusted survival from colorectal cancer,
Dukes Stage A (death from colorectal cancer) 1990 - 1995
Figure 5.3.4.7 - Age adjusted survival from colorectal cancer,
Dukes Stage C (death from colorectal cancer) 1990 - 1995
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Figure 5.3.4.8 - Age adjusted survival from colorectal cancer,
Dukes Stage D (death from colorectal cancer) 1990 - 1995
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Figures 5.3.4.5 to 5.3.4.8 are the age and stage adjusted survival curves,
where the end point is death from colorectal cancer. Here each figure
consistently shows that for each Dukes stage and age adjustment, the
northern First Nation group has the best survival pattern in comparison to the
other study groups. The survival curves in figures 5.3.4.5 and 5.3.4.6 are
relatively flat due to the small number of deaths for those diagnosed at Dukes
stage A and B respectively.
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6. Discussion and Conclusions
This descriptive study was done to explore and describe cancer survival
patterns in northern Saskatchewan First Nations and non-First Nations in
comparison to southern Saskatchewan First Nations and non-First Nations. It
was also done to explore factors, such as staging at time of diagnosis, that
could explain some of the disparity in the survival rates for cervical,
colorectal, and breast cancers experienced by northerners (First Nation and
non-First Nation) in comparison to southerners northerners (First Nation and
non-First Nation). This section will summarize and discuss the results
presented in chapter 5. It will begin with some discussion specific to each of
breast cancer, cervical cancer and colorectal cancer followed by some
summary discussion that is pertinent to aU three cancer sites.
6.1 Breast Cancer
The stage specific breast cancer distribution for the northern First
Nation and the southern First Nation groups were similar to one another. In
addition the stage specific breast cancer distribution for the two non-First
Nations groups were also similar to one another. For the two First Nation
groups there were a larger proportion of cases diagnosed at TNM stage II
versus TNM stage I. In contrast for the non-First Nations groups the
distribution of breast cancer cases at TNM stage I and TNM stage II were more
similar. This result concurs with research from other studies that concluded
102
that First Nations groups have more advanced disease at time of diagnosis(5,
40, 44). One possible explanation for this may be that First Nation groups
may not have equal geographical access to secondary prevention services in
comparison to non-First Nation groups. This explanation may not be the case
however. With the difference in the distribution of stage specific breast
cancer appearing between First Nations and non-First Nations and not on a
geographical basis (north versus south) perhaps geographical access would not
explain this difference in stage specific distribution. Further study of
geographical differences in access to services could be studied in order to
examine this hypothesis. A Geographical Information System (GIS) based
study could be carried out looking at physical distances to diagnostic and
screening services. Access to secondary prevention strategies can be
influenced by knowledge, awareness and attitudes of the individual towards
secondary prevention strategies, as well as the appropriateness of the
educational messages, and screening program strategies to the group that the
program is attempting to reach. For example, one may not feel the need to
go to see a health care professional for a regular check-up even if they are
feeling well and this could lead to a late stage diagnosis of cancer. Further
study into the attitudes and knowledge of First Nations could be done to
investigate this further. Another possible explanation of this difference may
be willingness to participate in screening programs, which may be influenced
by knowledge, awareness and attitudes towards screening (both self screening
through self examination and other screening such as clinical examination and
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mammography). Some previous studies have shown that First Nation
populations are not as willing to participate in screening programs(12, 44).
This couLd in turn mean that when First Nations do go for screening they
might have a higher stage of disease. Other factors that may be involved here
could be socio-economic status, education level, or culturaL beliefs. Further
study of these factors is needed to try to pinpoint the factors that could
explain why First Nation populations experience a higher proportion of breast
cancer cases at TNM stage II versus TNM stage I in comparison to non-First
Nation groups. Breast cancer five-year crude survival rates have been
calculated for northern First Nations (67%) and northern non-First Nations
(71 %) for the first time for Saskatchewan. Five-year crude survival rates for
the southern First Nation group (69%) and the southern non-First Nation
group(n%) have also been calculated and are comparable to rates calculated
in the literature(19). A very striking difference was seen in the causes of
death among breast cancer patients for the northern First Nation group.
Among those northern First Nation breast cancer patients who died, some 90%
died from breast cancer. For the other study groups 62% or less died of breast
cancer. This observation is further evident in the stage and age adjusted
survival curves where the end point is death from breast cancer. In
comparison to the survival curves from Cox's model where the end point is
death from aU causes the northern First Nation survival pattern comes out as
being quite different than aU three other study groups. Some caution must be
used in interpreting this result, as there were few cases in the northern First
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Nation group when using death from breast cancer as the end point. With
more deaths attributable to breast cancer the poorer survival pattern for the
northern First Nation group is expected. This poorer survival pattern may be
explained by hypothesizing that there is a greater impact of cancer therapy in
the other study groups in comparison to the northern non-First Nation group,
therefore those in the other study groups are getting "cured" from breast
cancer and eventually die of other causes. Either the therapy available to the
northern First Nation population is not as good as the other population groups,
or perhaps the willingness to go to and continue with therapy is not the same
for the northern First Nation group in comparison to the other population
groups. To investigate this further, a study of the type of treatment and
attendance of screening programs could be undertaken. One other
explanation may be that the death reporting mechanism for the northern First
Nation group may not be as accurate for some reason and therefore cancer is
used more often on the death certificate as the cause of death than some
other more detailed cause. Further investigation of this is necessary to help
understand what is the reason for this difference. The most interesting result
from the breast cancer analysis comes from the calculation of the relative risk
of dying from breast cancer using Cox's model. The relative risk of death
increases for each of the First Nations and northern non-First Nations when
age is taken into consideration. This shows that survival is even poorer than
calculated in the previous study (Irvine,1990) which did not adjust for age.
The relative risk of death decreases for each of the First Nations and northern
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non-First Nations groups when stage is taken into consideration. This shows
that the stage of disease at the time of diagnosis is one of the factors
involved in the differences in survival compared to the southern non-First
Nations group and may reflect differences in access, availability and
utilization of screening (including breast self examination, clinical breast
examination, or mammography). From the Cox's model, the age and stage
adjusted relative risk for dying from breast cancer for the northern First
Nation group was 1.81 in comparison to the southern non-First Nation group,
this was statistically significant (p=O.013). Despite adjusting for stage and
age, the relative risk was still significant for the northern First Nation group in
comparison to the southern non-First Nation group, factors other than stage
and age at time of diagnosis must therefore be involved. This result concurs
with Gilliland et al and Sugarman et al as they to found some unexplainE~d
difference in survival after adjusting for stage, age and other factors (211, 40).
Factors such as socio-economic status or treatment access may be tied to this
unexplained difference, further study of these factors is necessary.
6.2 Cervical Cancer
The stage specific cervical cancer distribution for the southern First
Nation group and southern non-First Nation groups were similar to one
another. In these two groups over half of the cervical cancer diagnoses were
at TNM stage I. For the two northern groups the distribution between TINM
stage I and TNM stage II were similar to each other, but a lower proportiion
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were in TNM stage I compared to the southern non-First Nations and southern
First Nations. The number of cases in the north with staging information was
small however. For the southern First Nation group this result is in contrast
with research from other studies that concluded that First Nations groups
have more advanced disease at time of diagnosis in comparison to non-First
Nations (5, 40, 44). Interestingly, although the southern First Nation group
had more diagnoses at TNM stage I than any other stage, their survival pattern
was worse than all other study groups. The relative risk of death for the
southern First Nation group was not significant however. This finding
warrants some more investigation, perhaps the influence of treatment should
be examined. Cervical cancer five-year crude survival rates have been
calculated for northern First Nations (69%) and northern non-First Nations
(69%) for the first time for Saskatchewan. Five-year crude survival rates for
the southern First Nation group (63%) and the southern non-First Nation group
(73%) have also been calculated. The rate calculated by Irvine et ale for all
First Nations was 75%, for the north (First Nation and non-First Nation) 66%,
and for the entire province 76%(6). In this study both First Nation groups had
lower five-year survival rates than the overall First Nation rate from Irvine et
al. Their study however, examined all cervical cancer diagnoses from 1967 to
1986, in comparison to this study, which included cervical cancer diagnoses
from 1980 to 1995. The crude five-year survival rate calculated in this study
includes more recent information and shows a slightly worse survival for First
Nations in Saskatchewan recently. In the previous study of cancer survival for
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the northern population of Saskatchewan(6), it was suggested that age at
time of diagnosis be investigated further as an influence on survival. This
study has accomplished this by calculating age and stage adjusted survival
using the Cox proportional hazards model. The relative risk of death increases
when adjusting for age which suggests that the survival rates are poorer than
calculated in the previous study, which did not consider the age differences in
the populations. The relative risk of death decreases for each of the First
Nations and the northern non-First Nations group when adjusting for stage at
time of diagnosis, suggesting that the stage at the time of diagnosis has some
influence on the differing survival rates. This may show the potential
improvement that is possible with improved screening. Despite adjusting for
both stage and age the southern First Nation relative risk is still statistically
significant in comparison to the southern non-First Nation group (death from
all causes). There are therefore still some unexplained differences in the
survival pattern. This concurs with Gilliland et al who also found that after
controlling for the distribution of age, gender, stage at diagnosis, histologic
grade, and treatment, disparities in survival were not completely
explained(40). Factors such as socio-economic related circumstances could
further explain this difference, further study into these factors is warranted.
As the southern First Nation group has the worst survival pattern when
examining stage and age adjusted survival, issues as to why must be asked.
Further study into the possible barriers faced by this population group must
be carried out. Factors such as willingness to attend treatment, education
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about screening and treatment, and cultural beliefs towards secondary
prevention strategies could contribute to their poor survival pattern. The
question of spending health care dollars on education programs on the
benefits of screening and following treatment versus having more
comprehensive and rigorous screening and treatment programs should also be
asked.
6.3 Colorectal Cancer
The stage specific colorectal cancer distribution for the two First
Nation groups and the northern non-First Nation group were similar to one
another. In these three groups almost 60% of the colorectal cancer diagnoses
were at Dukes stage C and D combined. For the southern non-First Nation
group the distribution of colorectal cancer at Dukes stage A and B combined
was over 50%. Looking at Dukes stage A, the two First Nation groups
(southern and northern) had the lowest proportion of cases followed by the
northern non-First nations and the southern non-First Nations. This has
implications on the importance of trying to achieve more early diagnoses for
these population groups. This could be attained by attempting to increase
awareness of the importance of regular check-ups, (Le. rectal exams) and
seeking attention for early symptoms. Caution should be used when
interpreting this data as the number of cases in the north and among southern
First Nations with staging information was small. For the southern First
Nation and northern First Nation groups this result is in accordance with
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research from other studies that concluded that First Nations groups have
more advanced disease at time of diagnosis in comparison to non-First Nations
(5, 40, 44). Colorectal cancer five-year crude survival rates have been
calculated for northern First Nations (82%) and northern non-First Nations
(59%) for the first time for Saskatchewan. Five-year crude survival rates for
the southern First Nation group (55%) and the southern non-First Nation group
(52%) have also been calculated. The rate calculated by Tan et al. for the
entire province was 54%(6) this is comparable to the rate for southern non-
First Nations (the largest population group in the province). Looking at the
relative risk of dying the northern First Nation group has the best survival
pattern in comparison to the other study groups when examining stage and
age adjusted survival. Further study into the possible reasons for this should
perhaps be undertaken as colorectal cancer rates have been shown to be
rising among First Nations throughout Saskatchewan and northern First
Nations on reserve(53).
6.4 Summary Discussion
This study provides a measure of cancer survival for the northern First
Nation and northern non-First Nation population groups for the province of
Saskatchewan. In the past, survival rates for the north of Saskatchewan have
been calculated for aU residents of the north, grouping First Nations and non-
First Nations together. By dividing the north into First Nation and non-First
Nation, a more complete understanding of the breast, cervical and colorectal
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cancer distribution and survival patterns have been shown. As Gillis et al
point out it is important to separate out First Nation and non-First Nation
information in the north to help understand fully the health status of these
two unique population groups in a unique geographical setting(5). This study
confirms in the Saskatchewan setting what the literature has pointed out,
both stage of cancer at time of diagnosis and age at time of diagnosis of
cancer are strong predictors of survival. The Cox proportional hazards model
analysis provides relative risk estimates that are highly significant with narrow
confidence intervals for both stage at diagnosis and age. This then shows that
for a more accurate estimation of the relative risk of dying from cancer, it is
worthwhile to control for factors such as age of cancer patient at time of
diagnosis and cancer stage at time of diagnosis. With regard to the impact of
stage of diagnosis on survival and access to secondary prevention strategies,
the findings of this study concur with those of Gilliland et al(40). They also
found that the stage adjusted relative risk estimate was slightly better than
the crude model however, they also found that there was still some
unexplained differences in the survival patterns between population groups,
as did this study. The results in this study however, were not found to be
significant for cervical and colorectal cancers, but these two sites had very
small number of cases and perhaps after more follow-up time the relative
risks may prove to be significant. Other factors that could influence survival
could be; type of treatment, participation in screening, cancer histology, and
socio-economic status, aU factors that have also been pointed out in the
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literature(38,40). It has been shown that when examining the survival curves
and relative risks for all sites (end point death from underlying cancer); for
breast cancer the northern First Nation group had visibly worse survival than
the other three study groups (statistically significant), for cervical cancer the
southern First Nation group had visibly worse survival than the other three
study groups (borderline significant), and for colorectal cancer the northern
First Nation group had a visibly better survival pattern than the three other
study groups (not statistically significant). Unexplained differences in
survival must be examined, factors such as socio-economic status and
attitudes and knowledge of secondary prevention strategies could be
examined to further understand these unexplained differences. In addition,
cancer treatment issues for the northern First Nation Group (breast cancer),
southern First Nation group (cervical cancer), and issues as to why the survival
pattern is better for the northern First Nation group for colorectal cancer
could also be examined. For colorectal and cervical cancers it must again be
pointed out that the number of cases were small and perhaps with a longer
follow-up time the results could be more interpretable.
Three main themes come out of this thesis; 1. the proportion of cancer
cases in early stage of disease is low for First Nation Groups and northerners
in comparison to southerners and non-First Nations this concurs with finding in
the literature(21, 40); 2. for each cancer site the relative risk of dying
increases for each study group in comparison to the southern non-First Nation
group when controlling for age, this allows for a more accurate indication of
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the true survival pattern for these groups as compared to studies in the
past(6); 3. the role of adjusting for stage of disease and age at time of
diagnosis with relation to survival and relative risk has been brought out. It is
important to improve access to screening, and make screening programs
appropriate to the geography, language and culture of First Nations
populations, this is evidenced by differences in the proportion of diagnoses at
later stages as well as relative risks calculated adjusting for stage at time of
diagnosis. Although adjusting for these factors has been shown to be valuable
in terms of a more accurate reflection of the true survival patterns of the
population groups, unexplained differences are still present and need to be
investigated.
6.5 Study Limitations
This study provides important information about severity of disease at
time of diagnosis of cancer through stage distribution and stage adjusted
survival analyses. These analyses are useful in helping understand the cancer
experience of the northern people of Saskatchewan, however, more
information is required to help understand the differences in survival and
relative risk between the north and the south. More accurate staging
information is required for other cancer sites so that similar studies can be
carried out for other cancer sites such as cancer of the lung. Information on
other covariates such as cancer histology, grading and type of treatment are
required to try and help explain differing survival patterns between First
Nations and non-First Nations, both in the north and the south. Other
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information on attitudes and knowledge towards secondary prevention
strategies and issues of socio-economic status must also be investigated.
There are few cases in some of the analyses done here thus risking a chance
of stating no significant differences when in fact there could be some
differences with a larger number of cases. A longer follow-up time is needed
to capture more cases for survival analysis. With more cases a more precise
estimate of the relative risk of dying of cancer for each study group can
perhaps be obtained.
6.6 Future Work
To better understand the cancer distribution and survival patterns
among northern First Nation and northern non-First Nation populations further
study needs to be under taken. Factors such as treatment, cancer histology,
and cancer grading and their effect on survival should be studied. Other
factors such as attitudes and knowledge of secondary prevention strategies
should also be examined. The role of socio-economic status may also be
important and therefore be further examined as well.
6.7 Conclusions
It is the hope of this author that this study can supply some information to the
people of the north and First Nations in Saskatchewan to help better
understand and pose further questions about their health status with respect
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to cancers of the breast, cervix and colon and rectum. With continued
interest and study of northern and First Nations populations perhaps the
health inequalities they have experienced in the past can be better
understood and even rectified.
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Appendix A: Map of Northern Saskatchewan
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First Nation Bands in Northern Saskatchewan
Appendix B:"Northern" Covered Population, 1992
Band
Clearwater Dene First Nation
Canoe Lake First Nation
Cumberland House First Nation
English River First Nation
Fond du Lac First Nation
Hatchet Lake First Nation
Lac La Ronge Indian Band
Montreal Lake First Nation
Peter Ballantyne Cree Nation
Buffalo River First Nation
Black Lake First Nation
Birch Narrows First Nation
Residence Code
74880 (Big C Band)
74680
72582
75180
75082
72882
72482
72682
72082
74780 (Peter Pond Lake Band)
74982 (Stony Rapids Band)
74580 (Turnor Lake Band)
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Communities in northern Saskatchewan with residence codes other than First
Nation Bands
Air Ronge 80470
Beauval 80370
Buffalo Narrows 80270
Camsell Portage 80170
Canoe Narrows 80371
Creighton 80530
Cumberland House 80570
Denare Beach 80571
Dillon 80271
Flin Flon/Creighton Unorg. area 80575
Fond du Lac 80172
Ile a la Crosse 80374
La Loche 80272
La Ronge 80430
Patuanak 80375
Pelican Narrows 80572
Pinehouse 80472
Sandy Bay 80573
Community Residence Code
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Southend 80473
Stanley Mission 80474
Stony Rapids 80173
Sturgeon Landing 80574
Timber Bay 80475
Turnor Lake 80273
Uranium City 80175
Weyakwin 80471
Wollaston Lake 80174
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